{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "start =  2018-02-02 12:48:01.495622\n",
      "end =  2018-02-02 12:49:35.586414\n",
      "total =  0:01:34.091090\n"
     ]
    }
   ],
   "source": [
    "import tarfile\n",
    "import re\n",
    "\n",
    "from datetime import datetime\n",
    "startTime = datetime.now()\n",
    "print(\"start = \", startTime)\n",
    "\n",
    "\n",
    "tar = tarfile.open('/project/data/non_comm_use.O-Z.xml.tar.gz', \"r:gz\")\n",
    "\n",
    "#5147743\n",
    "\n",
    "\n",
    "for filename in tar:\n",
    "    if re.search('11546864', filename.name) != None:\n",
    "        print(filename.name)\n",
    "        paper = tar.extractfile(filename)\n",
    "        print(paper.read())\n",
    "        break\n",
    "tar.close()\n",
    "\n",
    "print(\"end = \",  datetime.now())\n",
    "print(\"total = \",  datetime.now() - startTime )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [],
   "source": [
    "import tarfile\n",
    "import re\n",
    "from datetime import datetime\n",
    "\n",
    "def get_text_from_tar_file(PMID, list_tar_files):\n",
    "\n",
    "    startTime = datetime.now()\n",
    "    print(\"start = \", startTime)\n",
    "          \n",
    "    for file in list_tar_files:\n",
    "        file_path = '/project/data/' + file\n",
    "        print(file_path)\n",
    "\n",
    "        tar = tarfile.open(file_path, \"r:gz\")\n",
    "          \n",
    "        for filename in tar:\n",
    "            if re.search(PMID, filename.name) != None:\n",
    "                print(filename.name)\n",
    "                paper = tar.extractfile(filename)\n",
    "                print(paper.read())\n",
    "                tar.close()\n",
    "                return\n",
    "        tar.close()\n",
    "        \n",
    "        print(\"end = \",  datetime.now())\n",
    "        print(\"total = \",  datetime.now() - startTime )\n",
    "         \n",
    "          "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "137\tScience ---American Association for the Advanc...\t\n",
    "10.1126/science.293.5536.1793\t136\tNaN\t10.1126/science.314.5807.1875b\t11546864\t17185584"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [],
   "source": [
    "import string\n",
    "\n",
    "def list_tarfiles_to_check (initial_word):\n",
    "    \n",
    "    initial_word = initial_word.lower()\n",
    "    initial_letter = initial_word[0]\n",
    "    letter_index = string.ascii_lowercase.index(initial_letter)\n",
    "\n",
    "    # A-B\n",
    "    if letter_index <= 1:\n",
    "        files_to_check = [\"comm_use.A-B.xml.tar.gz\", \"non_comm_use.A-B.xml.tar.gz\"]\n",
    "    # C-H\n",
    "    if (2 <= letter_index) & (letter_index <= 7):\n",
    "        files_to_check = [\"comm_use.C-H.xml.tar.gz\", \"non_comm_use.C-H.xml.tar.gz\"]\n",
    "\n",
    "    # I-N\n",
    "    if (8 <= letter_index) & (letter_index <= 13):\n",
    "        files_to_check = [\"comm_use.I-N.xml.tar.gz\", \"non_comm_use.I-N.xml.tar.gz\"]\n",
    "\n",
    "    # O-Z\n",
    "    if (14 <= letter_index) & (letter_index <= 25):\n",
    "        files_to_check = [\"comm_use.O-Z.xml.tar.gz\", \"non_comm_use.O-Z.xml.tar.gz\"]\n",
    "\n",
    "    return files_to_check\n",
    "\n",
    "                               \n",
    "assert list_tarfiles_to_check(\"A Journal\") == [\"comm_use.A-B.xml.tar.gz\", \"non_comm_use.A-B.xml.tar.gz\"]\n",
    "assert list_tarfiles_to_check(\"C Journal\") == [\"comm_use.C-H.xml.tar.gz\", \"non_comm_use.C-H.xml.tar.gz\"]\n",
    "assert list_tarfiles_to_check(\"J Journal\") == [\"comm_use.I-N.xml.tar.gz\", \"non_comm_use.I-N.xml.tar.gz\"]\n",
    "assert list_tarfiles_to_check(\"S Journal\") == [\"comm_use.O-Z.xml.tar.gz\", \"non_comm_use.O-Z.xml.tar.gz\"]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "start =  2018-02-02 13:04:35.169531\n",
      "/project/data/comm_use.O-Z.xml.tar.gz\n",
      "OA_Fam_Med/PMC5147743.nxml\n",
      "b'<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type=\"nlm-journal-id\">101685426</journal-id><journal-id journal-id-type=\"pubmed-jr-id\">45398</journal-id><journal-id journal-id-type=\"nlm-ta\">OA Fam Med</journal-id><journal-id journal-id-type=\"iso-abbrev\">OA Fam Med</journal-id><journal-title-group><journal-title>OA family medicine</journal-title></journal-title-group><issn pub-type=\"epub\">2052-8922</issn></journal-meta><article-meta><article-id pub-id-type=\"pmid\">27942388</article-id><article-id pub-id-type=\"pmc\">5147743</article-id><article-id pub-id-type=\"manuscript\">HHSPA795764</article-id><article-categories><subj-group subj-group-type=\"heading\"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Aligning provider incentives to improve primary healthcare delivery in the United States</article-title></title-group><contrib-group><contrib contrib-type=\"author\"><name><surname>DeVoe</surname><given-names>JE</given-names></name><xref ref-type=\"aff\" rid=\"A1\">1</xref><xref ref-type=\"corresp\" rid=\"cor1\">*</xref></contrib><contrib contrib-type=\"author\"><name><surname>Stenger</surname><given-names>R</given-names></name><xref ref-type=\"aff\" rid=\"A2\">2</xref></contrib></contrib-group><aff id=\"A1\"><label>1</label>Department of Family Medicine, Oregon Health and Science University, 3181 Sam Jackson Park Road, Mailcode: FM, Portland, OR 97239, USA</aff><aff id=\"A2\"><label>2</label>Saint Patrick Hospital, 500 West Broadway Street, Missoula, MT 59802, USA</aff><author-notes><corresp id=\"cor1\"><label>*</label>Corresponding author. <email>devoej@ohsu.edu</email></corresp></author-notes><pub-date pub-type=\"nihms-submitted\"><day>29</day><month>6</month><year>2016</year></pub-date><pub-date pub-type=\"ppub\"><day>1</day><month>6</month><year>2013</year></pub-date><pub-date pub-type=\"pmc-release\"><day>09</day><month>12</month><year>2016</year></pub-date><volume>1</volume><issue>1</issue><fpage>7</fpage><lpage/><permissions><license license-type=\"open-access\" xlink:href=\"http://creativecommons.org/licenses/by/4.0/\"><license-p>Licensee OAPL (UK) 2013. Creative Commons Attribution License (CC-BY)</license-p></license></permissions><self-uri xlink:href=\"http://www.oapublishinglondon.com/article/958\"/><abstract><sec id=\"S1\"><title>Background</title><p id=\"P1\">The United States (US) is reforming primary care delivery systems, including the implementation of &#x02018;patient-centered medical homes.&#x02019; Alignment of provider incentives with desired outcomes will likely be important to the success of these delivery system reforms.</p></sec><sec id=\"S2\"><title>Methods</title><p id=\"P2\">This critical review uses a theoretical framework from game-theory models to discuss some of the dominant primary care provider payment models and how they create &#x02018;prisoner&#x02019;s dilemmas&#x02019; that have stalled past reform efforts. It then uses this framework to illustrate, hypothetically, how advantages from different models could be blended together to encourage cooperation and improve the quality of primary care services delivered, thus providing an escape from current prisoner&#x02019;s dilemmas faced by providers.</p></sec><sec id=\"S3\"><title>Findings</title><p id=\"P3\">Improvements in primary care delivery will largely hinge on blended payment mechanisms that can effectively combine the advantageous elements of fee-for-service, capitation, and incentive payments into a balanced equation that enables providers to escape the perverse financial incentives of current payment mechanisms and overcome collective action problems.</p></sec><sec id=\"S4\"><title>Conclusions</title><p id=\"P4\">If balanced appropriately, a blend of guaranteed payment and selective incentives designed to encourage primary care providers to deliver high quality care, efficient and equitable care and to eliminate incentives towards over-servicing could reach outcomes leading to shared benefits for everyone involved.</p></sec></abstract></article-meta></front><body><sec sec-type=\"intro\" id=\"S5\"><title>Introduction</title><sec id=\"S6\"><title>Background</title><p id=\"P5\">As the United States (US) grapples with fixing its broken health care system, reforming the primary care delivery system and implementing the &#x02018;patient-centered medical home&#x02019; model have featured prominently in recent debates.<sup><xref rid=\"R1\" ref-type=\"bibr\">1</xref>,<xref rid=\"R2\" ref-type=\"bibr\">2</xref>,<xref rid=\"R3\" ref-type=\"bibr\">3</xref>,<xref rid=\"R4\" ref-type=\"bibr\">4</xref>,<xref rid=\"R5\" ref-type=\"bibr\">5</xref>,<xref rid=\"R6\" ref-type=\"bibr\">6</xref></sup>.</p><p id=\"P6\">The 2010 Patient Protection and Affordable Care Act (the &#x02018;Obama Health Care Plan&#x02019;) included specific provisions for expanding new models of primary care.<sup><xref rid=\"R7\" ref-type=\"bibr\">7</xref></sup></p><p id=\"P7\">There is increasing awareness that changing the US primary care delivery system will also require changing payment and reimbursement models to better support patient-centered, comprehensive, coordinated and continuing care. Many experts have called for movement away from fee-for-service towards capitation or a blended payment approach.<sup><xref rid=\"R8\" ref-type=\"bibr\">8</xref>,<xref rid=\"R9\" ref-type=\"bibr\">9</xref>,<xref rid=\"R10\" ref-type=\"bibr\">10</xref>,<xref rid=\"R11\" ref-type=\"bibr\">11</xref>,<xref rid=\"R12\" ref-type=\"bibr\">12</xref></sup> However, there is currently limited information and serious skepticism about how (and if) a blended mechanism could work effectively.<sup><xref rid=\"R2\" ref-type=\"bibr\">2</xref>, <xref rid=\"R13\" ref-type=\"bibr\">13</xref>,<xref rid=\"R14\" ref-type=\"bibr\">14</xref>,<xref rid=\"R15\" ref-type=\"bibr\">15</xref>,<xref rid=\"R16\" ref-type=\"bibr\">16</xref></sup> In this critical review, we use the &#x02018;prisoner&#x02019;s dilemma&#x02019; aspect of economic game theory to highlight perversities inherent in current primary care payment mechanisms and to illuminate how blended payments might provide an escape from perverse financial incentives that prevent primary care providers from reforming the health care system to better promote health.<sup><xref rid=\"R17\" ref-type=\"bibr\">17</xref></sup></p></sec><sec id=\"S7\"><title>Definitions</title><p id=\"P8\">The term &#x02018;<bold>capitation</bold>&#x02019; has come to describe several aspects of the organization, management, delivery, and financing of health care services. Proponents of capitation argue that it creates incentives for population health management, efficiency and cost-containment while, at the same time, increasing the quality of services<sup><xref rid=\"R18\" ref-type=\"bibr\">18</xref>,<xref rid=\"R19\" ref-type=\"bibr\">19</xref>, <xref rid=\"R20\" ref-type=\"bibr\">20</xref>,<xref rid=\"R21\" ref-type=\"bibr\">21</xref></sup>. Opponents warn that the underlying incentives lead to under-servicing and the provision of inadequate care.<sup><xref rid=\"R22\" ref-type=\"bibr\">22</xref>,<xref rid=\"R23\" ref-type=\"bibr\">23</xref></sup> Capitation has been linked to public fears about the quality of care,<sup><xref rid=\"R22\" ref-type=\"bibr\">22</xref>,<xref rid=\"R24\" ref-type=\"bibr\">24</xref>,<xref rid=\"R25\" ref-type=\"bibr\">25</xref>,<xref rid=\"R26\" ref-type=\"bibr\">26</xref></sup> dissatisfaction among providers,<sup><xref rid=\"R27\" ref-type=\"bibr\">27</xref>,<xref rid=\"R28\" ref-type=\"bibr\">28</xref>,<xref rid=\"R29\" ref-type=\"bibr\">29</xref></sup> and the erosion of patient trust in medical professionals.<sup><xref rid=\"R30\" ref-type=\"bibr\">30</xref></sup></p><p id=\"P9\">For the purposes of this paper, capitation refers only to a mechanism of payment. Capitation involves arranging a global fee to be paid in advance to a provider (an individual, a group of providers, or an institution employing providers delivering primary care services) in return for the ongoing care of a patient over a specified period of time and across a defined scope of services. An exhaustive discussion of capitation formulas is beyond the scope of this paper, and can be found elsewhere.<sup><xref rid=\"R31\" ref-type=\"bibr\">31</xref>,<xref rid=\"R32\" ref-type=\"bibr\">32</xref>,<xref rid=\"R33\" ref-type=\"bibr\">33</xref>,<xref rid=\"R34\" ref-type=\"bibr\">34</xref>,<xref rid=\"R35\" ref-type=\"bibr\">35</xref>,<xref rid=\"R36\" ref-type=\"bibr\">36</xref>,<xref rid=\"R37\" ref-type=\"bibr\">37</xref>,<xref rid=\"R38\" ref-type=\"bibr\">38</xref></sup></p><p id=\"P10\">However, it is important to mention that most methods for calculating capitation rates attempt to risk adjust by taking into account the past history of diagnoses and service provision among a collective group of patients and providers. Regardless of the method used to estimate rates, a capitation contract transfers risk to providers. A provider stands to gain if the rate is higher than the level of service provided. Alternatively, a low rate will result in a financial loss for the provider. Further, there has been considerable debate about whether risk adjustment methodologies adequately predict the level of service needed by specific patients or populations.<sup><xref rid=\"R22\" ref-type=\"bibr\">22</xref>,<xref rid=\"R23\" ref-type=\"bibr\">23</xref>, <xref rid=\"R31\" ref-type=\"bibr\">31</xref>,<xref rid=\"R32\" ref-type=\"bibr\">32</xref>,<xref rid=\"R33\" ref-type=\"bibr\">33</xref>,<xref rid=\"R34\" ref-type=\"bibr\">34</xref>,<xref rid=\"R35\" ref-type=\"bibr\">35</xref>,<xref rid=\"R36\" ref-type=\"bibr\">36</xref>,<xref rid=\"R37\" ref-type=\"bibr\">37</xref></sup></p><p id=\"P11\">At the other end of the spectrum is <bold>fee-for-service</bold>, which pays a provider for each service. There are many formulas for determining fees, and procedural services are usually valued much higher than cognitive services. Fee-for-service has been criticized for providing incentives towards over-servicing.<sup><xref rid=\"R39\" ref-type=\"bibr\">39</xref>,<xref rid=\"R40\" ref-type=\"bibr\">40</xref>,<xref rid=\"R41\" ref-type=\"bibr\">41</xref></sup></p><p id=\"P12\">Fee-for-service models differ from capitation (simplistically) because providers are guaranteed a return on every effort expended, and thus have direct incentives to provide services that yield the highest payment, regardless of supporting evidence. If services are not required, providers do not get paid. Alternatively, providers benefit if the need (or desire) for services is abundant.<sup><xref rid=\"R42\" ref-type=\"bibr\">42</xref></sup></p><p id=\"P13\">In pure capitation and fee-for-service models, providers are relied upon to determine what services are necessary, and these same providers face a financial gain or loss from the provision of these services.<sup><xref rid=\"R43\" ref-type=\"bibr\">43</xref></sup> In each of these pure payment models, providers face financial incentives that create a &#x02018;dilemma,&#x02019; which juxtaposes maximizing financial reimbursement versus providing the right amount of services. To achieve optimal population health and an economically viable and sustainable health care system, it will be essential to create new models of provider payment that enable an escape from these dilemmas and foster &#x02018;cooperation&#x02019; among providers. We have coined the term &#x02018;cooperative jailbreak&#x02019; to represent an escape from the prisoner&#x02019;s dilemmas inherent in the most common provider reimbursement models.</p></sec><sec id=\"S8\" sec-type=\"methods\"><title>Methods</title><p id=\"P14\">In this section, we use aspects of the prisoner&#x02019;s dilemma model to frame discussions about the perverse incentives of current primary care provider reimbursement mechanisms and to illustrate, in theory, the potential for meaningful payment reform that could enable a focus on health.<sup><xref rid=\"R17\" ref-type=\"bibr\">17</xref></sup> We acknowledge the extent to which we have simplified assumptions in these models.</p><sec id=\"S9\"><title>Game Theory and the Prisoner&#x02019;s Dilemma Model</title><p id=\"P15\">Game theory has been used to predict the actions of individuals in strategic situations (or &#x02018;games&#x02019;) where the success of one individual depends on the actions of others.<sup><xref rid=\"R44\" ref-type=\"bibr\">44</xref>,<xref rid=\"R45\" ref-type=\"bibr\">45</xref></sup> The prisoner&#x02019;s dilemma describes a particular problem in a non-zero sum game where a &#x02018;player&#x02019; faces a choice to &#x02018;cooperate&#x02019; with other players or to &#x02018;defect.&#x02019; The resulting possible scenarios are classically represented in a 2&#x000d7;2 table (<xref ref-type=\"table\" rid=\"T1\">Table 1</xref>). The highest payoff for a player is to &#x02018;defect&#x02019; while the other players cooperate (BOX#3, Player 1). In this scenario, if only one player cooperates while the others defect, he or she receives the lowest payoff (BOX#2, Player 1). If all players cooperate, they each get the second highest payoff (Box #1), and if all defect, they each receive the second lowest payoff (Box #4).</p><p id=\"P16\">If only one cycle of the game is played, defection is the dominant strategy. This strategy is the only way a player is assured at least 1 point and has a chance to achieve 5 points. An assignment of strategies is termed a Nash equilibrium if no player could have improved his or her pay-off by deviating from the assigned strategy, given that all other players also play their assigned strategies.</p><p id=\"P17\">For example, if all players defect (<xref ref-type=\"table\" rid=\"T1\">Table 1</xref>, Box #4), no individual player could have improved his or her payoff by choosing to cooperate. If the game is repeated, however, there is potential for system-wide improvement if all players cooperate as indicated in <xref ref-type=\"table\" rid=\"T1\">Table 1</xref>, Box #1 which yields the most total points = 6 and an increase in the individual gain (3 points each). Individuals are faced with a &#x02018;prisoner&#x02019;s dilemma&#x02019; in deciding to either cooperate and hope the other player also cooperates (receiving the 2<sup>nd</sup> highest individual and the highest overall system pay-off) or to defect and hope the other player cooperates, thus earning the maximum individual payoff of 5 points. (This defection by only one player while all others cooperate is referred to as &#x02018;free riding,&#x02019; discussed further below.)</p></sec><sec id=\"S10\"><title>Adaptation of the &#x02018;Prisoner&#x02019;s Dilemma&#x02019; Model in Incentives in Primary Care</title><p id=\"P18\">The game-theoretic models illustrate the payoff for an individual provider, which depends on his or her own behavior and the behavior of all other providers. It is assumed that each provider&#x02019;s payment depends on three main components: financial remuneration, costs, and externalities, which are represented by five variables:\\n<list list-type=\"simple\" id=\"L1\"><list-item><p id=\"P19\"><bold>V</bold> - Volume of services</p></list-item><list-item><p id=\"P20\"><bold>Q</bold> - Quality of care</p></list-item><list-item><p id=\"P21\"><bold>C</bold> - Capitation rate</p></list-item><list-item><p id=\"P22\"><bold>E</bold> &#x02013; Externalities (i.e., benefits or costs that accrue to individual providers as a result of the overall environment)</p></list-item><list-item><p id=\"P23\"><bold>I</bold> - Incentive payments - payments to individual providers for specific outcomes (e.g., meeting quality benchmarks, coordination of care).</p></list-item></list>\\n</p><p id=\"P24\">The relevance of each variable to a provider&#x02019;s payoff depends, in large part, on the underlying payment mechanism (e.g., fee-for-service, capitation, blended payments). To a certain extent, it also depends on externalities, which represent the benefits or burdens accruing to a provider by the overall performance of the system of interconnected providers (e.g., a better than average performance of the medical system might improve health outcomes and, therefore, reduce future costs to all providers). Externalities are a result of the overall environment as determined by the collective action of most providers (e.g., standard of care, improvement of overall community health status).</p><p id=\"P25\">These game theoretic models are also built on the assumption that ultimate provider payment is based on the providers&#x02019; decisions about the volume and quality of service to provide. For simplicity, we assume providers can control the volume (<bold><italic>V</italic><sub>high</sub></bold> or <bold><italic>V</italic><sub>low</sub></bold>) and the quality of care (<bold><italic>Q</italic><sub>high</sub></bold> or <bold><italic>Q</italic><sub>low</sub></bold>) provided. We also assume that the externalities that accrue to individual providers depend primarily on the quality of care provided by most providers (if <bold>Q</bold>=<bold><italic>Q</italic><sub>high</sub></bold> then <bold>E</bold>=<bold><italic>E</italic><sub>highQ</sub></bold>). While the assumption of binary variables simplifies our models, a continuous representation of possible levels of service and quality would support similar conclusions. <xref ref-type=\"table\" rid=\"T1\">Table 1</xref> depicts two &#x02018;players&#x02019; in the game. In health care, Player 2 represents the collective group of &#x02018;others&#x02019; (usually more than one individual). The number of providers represented by Player 2 would likely influence the strategy choice (i.e., the more players involved, the more likely that defection of any one of them will occur). This potential for variable influence based on player scale is incorporated into the externality concept (E).</p></sec></sec></sec><sec sec-type=\"results\" id=\"S11\"><title>Results</title><sec id=\"S12\"><title>The Fee-for-Service Model</title><p id=\"P26\">Under the fee-for-service model, a provider&#x02019;s payment depends primarily on volume of services with little or no incentive to address quality, efficiency or equity in the provision of health care. There are no capitation or incentive payments. In addition, we assume that externalities resulting from an overall high quality of care could slightly reduce an individual provider&#x02019;s payoff by improving the health of the population and decreasing the need for more services. We present only a model of high volume, assuming that few or no providers would choose to provide a lower volume of service (which would yield a lower payment). Further, providers choosing to increase the quality of care in ways that do not generate a fee incur additional costs for which they do not receive compensation. Using these assumptions, we assigned the following values for each variable: V<sub>high</sub>=5, V<sub>low</sub>=3; C=0; E<sub>highQ</sub>=&#x02212;1, E<sub>lowQ</sub>=0; Q<sub>high</sub>=&#x02212;2, Q<sub>low</sub>=0; I=0. Thus, under a fee-for-service payment model, provider payment (PP) is represented by the formula: <bold><italic>PP = V+Q+E</italic></bold>. The four possible outcomes are represented in <xref ref-type=\"table\" rid=\"T2\">Table 2</xref>.</p><p id=\"P27\">Regardless of what other providers do, providing the highest number of low quality services is the dominant economic strategy for all agents. In game-theoretic terms, this becomes the (only) Nash equilibrium. This is consistent with the standard view that fee-for-service incentivizes over-servicing (charging the highest possible price to the patient and to the system). Under this model, there is no prisoner&#x02019;s dilemma as players have no incentive to cooperate with each other to equitably distribute services that maximize population health, as these efforts will likely diminish the individual economic payoff. Only in cases where maximization of individual payoff threatens the integrity of the overall system (i.e., high rates of uninsured individuals) would providers consider changing their dominant strategy.</p><p id=\"P28\">This representation of fee-for-service assumes providers would always choose quantity over quality to achieve maximum gain: low quality services are cheaper than high quality services, and thus would be the dominant economic strategy. This is the theoretical dominant strategy; however, in reality, we recognize that providers choices would vary based on multiple additional factors (e.g., desire to build good relationships with patients, altruism, etc). These non-economic influences, however, would serve to reduce maximum payoff.</p></sec><sec id=\"S13\"><title>The Capitation Model with a Short Time Horizon</title><p id=\"P29\">A capitation model with a short time horizon also yields one dominant strategy. In this model, a provider&#x02019;s payoff consists of a global capitation rate minus the cost (to the provider) of delivering care. We assume that most providers would choose to provide a lower volume of services, and providers that choose to increase the quality of care incur additional costs for which they do not receive compensation. There are no incentive payments, and we assume that externalities may minimally reduce providers&#x02019; costs if all providers deliver high quality care (and thus fewer patients may need a high volume of services). Using these assumptions, we assigned the following values for each variable: V<sub>high</sub>= &#x02212;2, V<sub>low</sub> =0; Q<sub>high</sub>=&#x02212;2, Q<sub>low</sub>=0; C= 5; E<sub>highQ</sub>=1, E<sub>lowQ</sub>=0; I=0. Thus, under a capitation model provider payment is represented by the formula <bold><italic>PP = V+Q+C+E</italic></bold> and the four possible outcomes are represented in <xref ref-type=\"table\" rid=\"T3\">Table 3</xref>.</p><p id=\"P30\">Again, regardless of what all other providers choose to do, the dominant strategy is to provide a low number of low quality services (<bold><italic>V</italic></bold> always = 0). Thus, low volume/low quality is, in game-theoretic terms, the (only) Nash equilibrium. This observation is consistent with the standard view that a pure capitation model sets a financial incentive to provide the lowest number and the lowest quality of services (and hope that other providers provide more adequate levels of service to maximize the externalities), regardless of the size of the capitation rate.</p><p id=\"P31\">This representation of capitation in game theoretic terms does assume providers would always choose the lowest quantity and lowest quality to achieve maximum gain, which is defined in a narrow economic sense here. In reality, we recognize that providers&#x02019; choices would vary based on multiple additional factors, which would serve to reduce maximum financial payoff but would have other non-financial benefits.</p></sec><sec id=\"S14\"><title>The Capitation Model with a Longer Time Horizon &#x02013; (A Prisoner&#x02019;s Dilemma)</title><p id=\"P32\">If future capitation rates are based on prior costs, the dominant strategy in <xref ref-type=\"table\" rid=\"T3\">Table 3</xref> has the potential to backfire over a longer time horizon. If the collective group of providers repeatedly delivers a low volume of low quality services, the global capitation rate for future periods is likely to decrease (as will the health of the population requiring the need for a higher volume of services in the future). <xref ref-type=\"table\" rid=\"T4\">Table 4</xref> shows the payoff matrix for a future period of time when the capitation rate has either remained high based on prior high overall quality or decreased significantly based on prior low overall quality (<bold><italic>C</italic></bold>= either <bold><italic>C</italic></bold><sub>highQ</sub>=5 or <bold><italic>C</italic></bold><sub>lowQ</sub>=3). We assume the other variables retain the same values as in the previous short-term capitation example.</p><p id=\"P33\">Once more, the (unique) Nash equilibrium is to deliver a low volume of low quality services. But this time, the situation is a prisoner&#x02019;s dilemma, because the overall system payoff (and individual payoff in the long term) could be increased if all providers cooperated to deliver high quality care. Each provider is faced with a collective action problem of the kind famously identified by Mancur Olson<sup><xref rid=\"R44\" ref-type=\"bibr\">44</xref></sup>: future payoff depends on the externalities of the average quality of services, which depends on the present choices of all providers. But each provider has an incentive to free-ride, which discourages collective action. If most other providers offer high quality service (costing them more per service), an individual provider benefits from being in this environment with an adequate supply of high quality services (or by &#x02018;cherry-picking&#x02019; the most healthy patients), irrespective of this provider&#x02019;s contribution.<sup><xref rid=\"R46\" ref-type=\"bibr\">46</xref>, <xref rid=\"R47\" ref-type=\"bibr\">47</xref></sup> And, if most others choose the dominant strategy and continue to provide low quality services, an individual provider is adversely affected by being the only one who makes the necessary investments to provide high quality services (or to provide care for the most vulnerable patients with the highest co-morbidities).</p><p id=\"P34\">The prisoner&#x02019;s dilemma lies in the fact that individually rational behavior (defined in the game-theoretic terms as pursuing the highest individual payoff) leads to a collectively sub-optimal outcome. In order to achieve the collectively superior outcome, or a &#x02018;cooperative jailbreak&#x02019; from the prisoner&#x02019;s dilemma, a cooperative disposition against the incentive to free-ride would be required on the part of every provider. This could be accomplished by adding appropriate incentives into the system to encourage providers to &#x02018;do the right thing.&#x02019; In addition, the rules governing the system must allow for cooperation amongst providers.<sup><xref rid=\"R48\" ref-type=\"bibr\">48</xref>, <xref rid=\"R49\" ref-type=\"bibr\">49</xref></sup></p></sec><sec id=\"S15\"><title>Blended Payments &#x02013; A Cooperative Jailbreak That Decreases the Potential to Free-Ride?</title><p id=\"P35\">Could blended payment mechanisms help providers escape the urge to free-ride? Could blended payments incentivize high quality care delivered efficiently and equitably while also ensuring the appropriate use of evidence-based information?<sup><xref rid=\"R50\" ref-type=\"bibr\">50</xref>&#x02013;<xref rid=\"R53\" ref-type=\"bibr\">53</xref></sup> Several experts have contributed to theoretical discussions about how to solve the prisoner&#x02019;s dilemma and other related collective action problems.<sup><xref rid=\"R45\" ref-type=\"bibr\">45</xref>, <xref rid=\"R54\" ref-type=\"bibr\">54</xref>, <xref rid=\"R55\" ref-type=\"bibr\">55</xref></sup> One solution involves changing the incentive structure, so as to remove the prisoner&#x02019;s dilemma. Specifically, in addition to the collective benefits from maximizing quality, the idea is to create benefits that accrue selectively for each provider on the basis of whether he or she chooses to provide high or low quality care and the appropriate volume of services.</p><p id=\"P36\">The predominant blended payment models involve three components: (1) fee-for-service payments for some services, (2) a prospective care-management capitation fee, and (3) incentive payments based on achieving some desirable outcomes (e.g., achieving benchmarks, meaningful use of an electronic medical record).<sup><xref rid=\"R8\" ref-type=\"bibr\">8</xref>, <xref rid=\"R56\" ref-type=\"bibr\">56</xref></sup> In such a system, a provider&#x02019;s base payment could be dominated either by the fee-for-service or capitation portions, and the additional incentive payments could be either large or small relative to the primary source of payment. In this situation, provider payment is calculated as follows: <bold><italic>PP= V+Q+C+E+I</italic></bold> where incentive payments (<bold><italic>I</italic></bold>) would be dependent on an individual provider&#x02019;s quality of care in some prior period.</p><p id=\"P37\"><xref ref-type=\"table\" rid=\"T5\">Table 5</xref> demonstrates the impact of adding a small or a big incentive payment to a model that is predominantly based on fee-for-service or capitation. To reach a maximum payment =6, we first assumed that a small incentive payment (<bold><italic>I</italic></bold>=1) would be a small percentage (e.g., 20%) of a &#x02018;base&#x02019; fee-for-service+capitation payment of 5. When the quality of services is high, then <bold><italic>I</italic></bold><sub>highQ</sub>=1; when quality is low, then <bold><italic>I</italic></bold><sub>lowQ</sub>=0. Or, alternatively, assume that a bigger incentive payment (I=2) would be a larger percentage (e.g., 50%) of a slightly lower &#x02018;base&#x02019; payment of 4. In this example, when the quality of services is high then <bold><italic>I</italic></bold><sub>highQ</sub>=2; when quality is low, then <bold><italic>I</italic></bold><sub>lowQ</sub>=0. We also assume that the addition of any fee-for-service payment will encourage a higher volume of services.</p><p id=\"P38\"><xref ref-type=\"table\" rid=\"T5\">Tables 5a and 5b</xref> include a small incentive payment; the Nash equilibrium is for all providers to provide a high volume of low quality services. There is also the temptation to free ride by providing low quality services in a high quality environment. In <xref ref-type=\"table\" rid=\"T5\">Tables 5c and 5d</xref>, which includes a slightly lower base and bigger incentive payment, however, there is no Nash equilibrium and no incentive to free ride. Thus, an individual provider could potentially be motivated to choose the strategy of high volume/high quality that provides the greatest collective benefit. If future capitation rates in examples c and d were risk-adjusted based on the delivery of current high quality care (as in <xref ref-type=\"table\" rid=\"T4\">table 4</xref>), the incentive for providers to deliver high quality care could potentially be magnified.</p></sec></sec><sec sec-type=\"discussion\" id=\"S16\"><title>Discussion</title><p id=\"P39\">Payment models are central to health care delivery and will be key to improving the primary care delivery system. There is a need to investigate how different incentive structures could lead to the delivery of high quality care, efficiency and equity.<sup><xref rid=\"R17\" ref-type=\"bibr\">17</xref></sup> Game theoretic models are useful to heuristically highlight how different payment models might work in real-world settings. Whether or not, and to what extent, providers actually face collective action problems depends on many empirical specifics. For example, for a longer-term capitation model to create a prisoner&#x02019;s dilemma: (1) future capitation rates must closely track the previous average level of service, and (2) positive externalities of a high average quality of care must affect individual providers.</p><p id=\"P40\">If both criteria hold true, to some extent, providers face a serious prisoner&#x02019;s dilemma that could potentially be made better or worse by introducing alternative payment methodologies into new primary care delivery models.<sup><xref rid=\"R3\" ref-type=\"bibr\">3</xref>, <xref rid=\"R57\" ref-type=\"bibr\">57</xref></sup> One such alternative is a blended payment mechanism that effectively combines the elements of fee-for-service, capitation, and incentive payments.<sup><xref rid=\"R50\" ref-type=\"bibr\">50</xref>, <xref rid=\"R51\" ref-type=\"bibr\">51</xref>,<xref rid=\"R52\" ref-type=\"bibr\">52</xref>,<xref rid=\"R58\" ref-type=\"bibr\">58</xref>,<xref rid=\"R59\" ref-type=\"bibr\">59</xref></sup> Blended payments have the potential to tip the incentive structure towards cooperation, resulting in improved health care delivery, maximizing population health and minimizing costs&#x02014;achieving the &#x02018;triple aim.&#x02019;<sup><xref rid=\"R60\" ref-type=\"bibr\">60</xref></sup></p><p id=\"P41\">But, the applicability of these models also depends on the ability of providers to effectively collaborate and to overcome many of the obstacles that have made it difficult to build synergistic partnerships in the past.<sup><xref rid=\"R48\" ref-type=\"bibr\">48</xref>,<xref rid=\"R61\" ref-type=\"bibr\">61</xref>,<xref rid=\"R62\" ref-type=\"bibr\">62</xref>,<xref rid=\"R63\" ref-type=\"bibr\">63</xref>,<xref rid=\"R64\" ref-type=\"bibr\">64</xref>,<xref rid=\"R65\" ref-type=\"bibr\">65</xref></sup></p><p id=\"P42\">The inclusion of a pay-for-performance component (e.g., fee-for-service) in blended payment models also warrants some discussion. For the purposes of our models, we assume that this component would encourage providers to deliver a higher volume of services, which has been shown in recent empiric studies.<sup><xref rid=\"R66\" ref-type=\"bibr\">66</xref>,<xref rid=\"R67\" ref-type=\"bibr\">67</xref></sup> To the extent that care delivered by a primary care provider is relatively efficient compared to similar care delivered in other settings,<sup><xref rid=\"R68\" ref-type=\"bibr\">68</xref>,<xref rid=\"R69\" ref-type=\"bibr\">69</xref>,<xref rid=\"R70\" ref-type=\"bibr\">70</xref>,<xref rid=\"R71\" ref-type=\"bibr\">71</xref>,<xref rid=\"R72\" ref-type=\"bibr\">72</xref></sup> we believe it may be necessary to retain a mechanism that encourages primary care providers to offer a higher volume of appropriate services themselves, rather than refer cases out.<sup><xref rid=\"R73\" ref-type=\"bibr\">73</xref></sup></p><sec id=\"S17\"><title>Special Considerations and Next Step</title><p id=\"P43\">The capitation model that extends over a longer time horizon is still finite and thus cannot account for special circumstances, such as an individual solo practitioner nearing retirement who may revert back to the dominant behavior of those providers with only a short horizon.</p><p id=\"P44\">We also acknowledge that individual providers are rarely isolated or independent; rather, they are part of a highly interconnected network of providers, and the behavior of each provider (and multiple third parties) will affect the others. Generally, the relevance of game theory models depends on how strongly the effects of different providers&#x02019; actions are interconnected. Further, the type of provider (e.g., solo practice, small group practice, large group network) being reimbursed greatly affects the model, and complex systems might contain different levels of payment (i.e., an individual provider may have a different incentive system than the larger entity). Regardless of size and underlying structure, however, all providers ultimately do face decisions regarding the volume of services to provide and the quality of those services.</p><p id=\"P45\">The purpose of this paper is not to provide a comprehensive description of the highly complex economic mechanisms and incentive structures in health care systems. We recognize that more sophisticated frameworks are needed to develop and refine blended payment models that achieve true payment reform and optimally improve health care delivery that better achieves health.</p><p id=\"P46\">We propose that case studies describing empiric tests of how these theoretical models could apply to and be modified by &#x02018;real world&#x02019; settings and demonstrations of practice transformation are logical next steps.</p></sec></sec><sec sec-type=\"conclusions\" id=\"S18\"><title>Conclusions</title><p id=\"P47\">We highlight a novel theoretical framework to review predominant payment models and to inform efforts to align payment incentives to improve primary health care delivery. Both empirical investigations (i.e., current pilot or demonstration projects) and detailed modeling of blended payment schemes are needed to determine how to design incentives that will make the delivery of high quality care the dominant strategy for every health care provider and system. If successful, the right combinations of ethical incentives built upon sound form of blended payment could provide a cooperative jailbreak from prisoner&#x02019;s dilemmas and ultimately lead towards an integration of care and innovation in system design.<sup><xref rid=\"R22\" ref-type=\"bibr\">22</xref>,<xref rid=\"R39\" ref-type=\"bibr\">39</xref>,<xref rid=\"R58\" ref-type=\"bibr\">58</xref></sup></p><p id=\"P48\">The rapid adoption of new health care delivery models and provider payment schemes, despite little empirical evidence, has created daunting challenges for researchers: How might experiments in provider payment within these new demonstration projects impact the current health care system?<sup><xref rid=\"R3\" ref-type=\"bibr\">3</xref></sup> More pressing, is it even possible to reach the goal of a payment system that promotes both increased quality and reduced costs?<sup><xref rid=\"R13\" ref-type=\"bibr\">13</xref>, <xref rid=\"R50\" ref-type=\"bibr\">50</xref></sup> This paper was intended to shed some optimistic light on how we might meet this challenge with regards to the reimbursement of primary care providers. We hope that our illustration of the theoretic potential of blended payments will encourage further research and development of blended payment models.</p></sec></body><back><fn-group><fn id=\"FN1\"><p id=\"P49\">Competing interests: None declared.</p></fn><fn fn-type=\"COI-statement\" id=\"FN2\"><p id=\"P50\">Conflict of interests: None declared.</p></fn><fn id=\"FN3\" fn-type=\"con\"><p id=\"P51\">All authors contributed to conception and design, manuscript preparation, read and approved the final manuscript.</p></fn><fn id=\"FN4\"><p id=\"P52\">All authors abide by the Association for Medical Ethics (AME) ethical rules of disclosure.</p></fn></fn-group><ack id=\"S19\"><p id=\"P53\">The authors wish to thank Professors Avner Offer, Christian List, and John Saultz. J.D.&#x02019;s time on this project was partially funded by grant numbers 5 F32 HS014645 and 1 K08 HS16181 from the Agency for Healthcare Research and Quality (AHRQ) and from the Oregon Health and Science University Department of Family Medicine Research Program.</p></ack><ref-list><title>References</title><ref id=\"R1\"><label>1</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Rittenhouse</surname><given-names>DR</given-names></name><name><surname>Shortell</surname><given-names>SM</given-names></name></person-group><article-title>The Patient-Centered Medical Home: Will It Stand the Test of Health Reform?</article-title><source>JAMA</source><year>2009</year><volume>301</volume><issue>19</issue><fpage>2038</fpage><lpage>2040</lpage><pub-id pub-id-type=\"pmid\">19454643</pub-id></element-citation></ref><ref id=\"R2\"><label>2</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Gottlieb</surname><given-names>LM</given-names></name></person-group><article-title>Learning from Alma Ata: The Medical Home and Comprehensive Primary Health Care</article-title><source>J Am Board Fam Med</source><year>2009</year><volume>22</volume><issue>3</issue><fpage>242</fpage><lpage>246</lpage><pub-id pub-id-type=\"pmid\">19429729</pub-id></element-citation></ref><ref id=\"R3\"><label>3</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Nutting</surname><given-names>PA</given-names></name><name><surname>Miller</surname><given-names>WL</given-names></name><name><surname>Crabtree</surname><given-names>BF</given-names></name><name><surname>Jaen</surname><given-names>CR</given-names></name><name><surname>Stewart</surname><given-names>EE</given-names></name><name><surname>Stange</surname><given-names>KC</given-names></name></person-group><article-title>Initial Lessons From the First National Demonstration Project on Practice Transformation to a Patient-Centered Medical Home</article-title><source>Ann Fam Med</source><year>2009</year><volume>7</volume><issue>3</issue><fpage>254</fpage><lpage>260</lpage><pub-id pub-id-type=\"pmid\">19433844</pub-id></element-citation></ref><ref id=\"R4\"><label>4</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Iglehart</surname><given-names>JK</given-names></name></person-group><article-title>No Place Like Home -- Testing a New Model of Care Delivery</article-title><source>N Engl J Med</source><year>2008</year><volume>359</volume><issue>12</issue><fpage>1200</fpage><lpage>1202</lpage><pub-id pub-id-type=\"pmid\">18799555</pub-id></element-citation></ref><ref id=\"R5\"><label>5</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Huerta</surname><given-names>TR</given-names></name><name><surname>Sieck</surname><given-names>CJ</given-names></name><name><surname>Hefner</surname><given-names>J</given-names></name><name><surname>Johansen</surname><given-names>M</given-names></name><name><surname>Wexler</surname><given-names>R</given-names></name><name><surname>McAlearney</surname><given-names>AS</given-names></name></person-group><article-title>Patient Centered Care plus Medical Home does not equal Patient Centered Medical Home: Why layering models of care may not lead to better outcomes</article-title><source>OA Family Medicine</source><year>2013</year><volume>1</volume><issue>1</issue><fpage>5</fpage></element-citation></ref><ref id=\"R6\"><label>6</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Jaen</surname><given-names>CR</given-names></name><name><surname>Ferrer</surname><given-names>RL</given-names></name><name><surname>Miller</surname><given-names>WL</given-names></name><etal/></person-group><article-title>Patient Outcomes at 26 Months in the Patient-Centered Medical Home National Demonstration Project</article-title><source>The Annals of Family Medicine</source><year>2010</year><volume>8</volume><issue>Suppl_1</issue><fpage>S57</fpage><lpage>S67</lpage><pub-id pub-id-type=\"pmid\">20530395</pub-id></element-citation></ref><ref id=\"R7\"><label>7</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Goodson</surname><given-names>JD</given-names></name></person-group><article-title>Patient Protection and Affordable Care Act: promise and peril for primary care</article-title><source>Annals of Internal Medicine</source><year>2010</year><volume>152</volume><issue>11</issue><fpage>742</fpage><lpage>744</lpage><pub-id pub-id-type=\"pmid\">20404263</pub-id></element-citation></ref><ref id=\"R8\"><label>8</label><element-citation publication-type=\"confproc\"><collab>American College of Physicians</collab><article-title>A System in Need of Change: Restructuring Payment Policies to Support Patient-Centered Care</article-title><source>Position Paper of the American College of Physicians</source><year>2006</year></element-citation></ref><ref id=\"R9\"><label>9</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Goroll</surname><given-names>AH</given-names></name><name><surname>Berenson</surname><given-names>RA</given-names></name><name><surname>Schoenbaum</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Fundamental reform of payment for adult primary care: comprehensive payment for comprehensive care</article-title><source>J Gen Intern Med</source><year>2007</year><volume>22</volume><issue>3</issue><fpage>410</fpage><lpage>415</lpage><pub-id pub-id-type=\"pmid\">17356977</pub-id></element-citation></ref><ref id=\"R10\"><label>10</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Berenson</surname><given-names>RA</given-names></name><name><surname>Rich</surname><given-names>EC</given-names></name></person-group><article-title>How to buy a medical home? Policy options and practical questions</article-title><source>Journal of General Internal Medicine</source><year>2010</year><volume>25</volume><issue>6</issue><fpage>619</fpage><lpage>624</lpage><pub-id pub-id-type=\"pmid\">20467911</pub-id></element-citation></ref><ref id=\"R11\"><label>11</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Merrell</surname><given-names>K</given-names></name><name><surname>Berenson</surname><given-names>RA</given-names></name></person-group><article-title>Structuring payment for medical homes</article-title><source>Health Affairs</source><year>2010</year><volume>29</volume><issue>5</issue><fpage>852</fpage><lpage>858</lpage><pub-id pub-id-type=\"pmid\">20439871</pub-id></element-citation></ref><ref id=\"R12\"><label>12</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Olson</surname><given-names>A</given-names></name></person-group><article-title>Primary-Care Physician Compensation</article-title><source>Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine</source><year>2012</year><volume>79</volume><issue>4</issue><fpage>490</fpage><lpage>496</lpage></element-citation></ref><ref id=\"R13\"><label>13</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Dudley</surname><given-names>RA</given-names></name></person-group><article-title>Pay-for-performance research: how to learn what clinicians and policy makers need to know</article-title><source>Journal of the American Medical Association</source><year>2005</year><volume>294</volume><issue>14</issue><fpage>1821</fpage><lpage>1823</lpage><pub-id pub-id-type=\"pmid\">16219887</pub-id></element-citation></ref><ref id=\"R14\"><label>14</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Rosenthal</surname><given-names>MB</given-names></name><name><surname>Frank</surname><given-names>RG</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Epstein</surname><given-names>AM</given-names></name></person-group><article-title>Early experience with pay-for-performance: from concept to practice</article-title><source>Journal of the American Medical Association</source><year>2005</year><volume>294</volume><issue>14</issue><fpage>1788</fpage><lpage>1793</lpage><pub-id pub-id-type=\"pmid\">16219882</pub-id></element-citation></ref><ref id=\"R15\"><label>15</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Fink</surname><given-names>KS</given-names></name></person-group><article-title>Value-Driven Health Care: Proceed With Caution</article-title><source>J Am Board Fam Med</source><year>2008</year><volume>21</volume><issue>5</issue><fpage>458</fpage><lpage>460</lpage><pub-id pub-id-type=\"pmid\">18772300</pub-id></element-citation></ref><ref id=\"R16\"><label>16</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Rogers</surname><given-names>JC</given-names></name></person-group><article-title>The Patient-Centered Medical Home Movement--Promise and Peril for Family Medicine</article-title><source>J Am Board Fam Med</source><year>2008</year><volume>21</volume><issue>5</issue><fpage>370</fpage><lpage>374</lpage><pub-id pub-id-type=\"pmid\">18772290</pub-id></element-citation></ref><ref id=\"R17\"><label>17</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Sturmberg</surname><given-names>J</given-names></name></person-group><article-title>Think health &#x02013; speak health &#x02013; achieve health</article-title><source>OA Family Medicine</source><year>2013</year><volume>1</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id=\"R18\"><label>18</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Miller</surname><given-names>RH</given-names></name><name><surname>Luft</surname><given-names>HS</given-names></name></person-group><article-title>Managed care plan performance since 1980. A literature analysis</article-title><source>JAMA</source><year>1994</year><volume>271</volume><issue>19</issue><fpage>1512</fpage><lpage>1519</lpage><pub-id pub-id-type=\"pmid\">8176832</pub-id></element-citation></ref><ref id=\"R19\"><label>19</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Freund</surname><given-names>DA</given-names></name><name><surname>Rossiter</surname><given-names>LF</given-names></name><name><surname>Fox</surname><given-names>PD</given-names></name><etal/></person-group><article-title>Evaluation of the Medicaid competition demonstrations</article-title><source>Health Care Financ Rev</source><year>1989</year><volume>11</volume><issue>2</issue><fpage>81</fpage><lpage>97</lpage><pub-id pub-id-type=\"pmid\">10313460</pub-id></element-citation></ref><ref id=\"R20\"><label>20</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Retchin</surname><given-names>SM</given-names></name><name><surname>Brown</surname><given-names>B</given-names></name></person-group><article-title>The quality of ambulatory care in Medicare health maintenance organizations [see comments]</article-title><source>Am J Public Health</source><year>1990</year><volume>80</volume><issue>4</issue><fpage>411</fpage><lpage>415</lpage><pub-id pub-id-type=\"pmid\">2107765</pub-id></element-citation></ref><ref id=\"R21\"><label>21</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Barr</surname><given-names>N</given-names></name></person-group><article-title>Economic theory and the welfare state: a survey and interpretation</article-title><source>Journal of Economic Literature</source><year>1992</year><volume>30</volume><fpage>741</fpage><lpage>803</lpage></element-citation></ref><ref id=\"R22\"><label>22</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Pearson</surname><given-names>SD</given-names></name><name><surname>Sabin</surname><given-names>JE</given-names></name><name><surname>Emanuel</surname><given-names>EJ</given-names></name></person-group><article-title>Ethical guidelines for physician compensation based on capitation [see comments]</article-title><source>N Engl J Med</source><year>1998</year><volume>339</volume><issue>10</issue><fpage>689</fpage><lpage>693</lpage><pub-id pub-id-type=\"pmid\">9725929</pub-id></element-citation></ref><ref id=\"R23\"><label>23</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kassirer</surname><given-names>JP</given-names></name></person-group><article-title>Managed care and the morality of the marketplace [editorial] [see comments]</article-title><source>N Engl J Med</source><year>1995</year><volume>333</volume><issue>1</issue><fpage>50</fpage><lpage>52</lpage><pub-id pub-id-type=\"pmid\">7776996</pub-id></element-citation></ref><ref id=\"R24\"><label>24</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Freudenheim</surname><given-names>M</given-names></name></person-group><article-title>HMOs cope with a backlash on cost cutting</article-title><source>New York Times</source><year>1996</year><month>5</month><day>19</day><fpage>1</fpage></element-citation></ref><ref id=\"R25\"><label>25</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Blendon</surname><given-names>RJ</given-names></name><name><surname>Hyams</surname><given-names>TS</given-names></name><name><surname>Benson</surname><given-names>JM</given-names></name></person-group><article-title>Bridging the gap between expert and public views on health care reform</article-title><source>JAMA</source><year>1993</year><volume>269</volume><issue>19</issue><fpage>2573</fpage><lpage>2578</lpage><pub-id pub-id-type=\"pmid\">8487426</pub-id></element-citation></ref><ref id=\"R26\"><label>26</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Felsenthal</surname><given-names>E</given-names></name></person-group><article-title>When HMOs say no to health coverage, more patients are taking them to court</article-title><source>Wall Street Journal</source><year>1996</year><month>5</month><day>17</day><volume>B</volume><fpage>1</fpage></element-citation></ref><ref id=\"R27\"><label>27</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Simon</surname><given-names>SR</given-names></name><name><surname>Pan</surname><given-names>RJ</given-names></name><name><surname>Sullivan</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Views of managed care--a survey of students, residents, faculty, and deans at medical schools in the United States [see comments]</article-title><source>N Engl J Med</source><year>1999</year><volume>340</volume><issue>12</issue><fpage>928</fpage><lpage>936</lpage><pub-id pub-id-type=\"pmid\">10089187</pub-id></element-citation></ref><ref id=\"R28\"><label>28</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kerr</surname><given-names>EA</given-names></name><name><surname>Mittman</surname><given-names>BS</given-names></name><name><surname>Hays</surname><given-names>RD</given-names></name><name><surname>Zemencuk</surname><given-names>JK</given-names></name><name><surname>Pitts</surname><given-names>J</given-names></name><name><surname>Brook</surname><given-names>RH</given-names></name></person-group><article-title>Associations between primary care physician satisfaction and self- reported aspects of utilization management</article-title><source>Health Serv Res</source><year>2000</year><volume>35</volume><issue>1 Pt 2</issue><fpage>333</fpage><lpage>349</lpage><pub-id pub-id-type=\"pmid\">10778819</pub-id></element-citation></ref><ref id=\"R29\"><label>29</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bodenheimer</surname><given-names>T</given-names></name></person-group><article-title>The American health care system--physicians and the changing medical marketplace</article-title><source>N Engl J Med</source><year>1999</year><volume>340</volume><issue>7</issue><fpage>584</fpage><lpage>588</lpage><pub-id pub-id-type=\"pmid\">10021483</pub-id></element-citation></ref><ref id=\"R30\"><label>30</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kao</surname><given-names>AC</given-names></name><name><surname>Green</surname><given-names>DC</given-names></name><name><surname>Zaslavsky</surname><given-names>AM</given-names></name><name><surname>Koplan</surname><given-names>JP</given-names></name><name><surname>Cleary</surname><given-names>PD</given-names></name></person-group><article-title>The relationship between method of physician payment and patient trust [see comments]</article-title><source>JAMA</source><year>1998</year><volume>280</volume><issue>19</issue><fpage>1708</fpage><lpage>1714</lpage><pub-id pub-id-type=\"pmid\">9832007</pub-id></element-citation></ref><ref id=\"R31\"><label>31</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Iezzoni</surname><given-names>LI</given-names></name><name><surname>Ayanian</surname><given-names>JZ</given-names></name><name><surname>Bates</surname><given-names>DW</given-names></name><name><surname>Burstin</surname><given-names>HR</given-names></name></person-group><article-title>Paying more fairly for Medicare capitated care [see comments]</article-title><source>N Engl J Med</source><year>1998</year><volume>339</volume><issue>26</issue><fpage>1933</fpage><lpage>1938</lpage><pub-id pub-id-type=\"pmid\">9862953</pub-id></element-citation></ref><ref id=\"R32\"><label>32</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Greenwald</surname><given-names>LM</given-names></name><name><surname>Esposito</surname><given-names>A</given-names></name><name><surname>Ingber</surname><given-names>MJ</given-names></name><name><surname>Levy</surname><given-names>JM</given-names></name></person-group><article-title>Risk Adjustment for the Medicare program: lessons learned from research and demonstrations</article-title><source>Inquiry</source><year>1998</year><volume>35</volume><issue>2</issue><fpage>193</fpage><lpage>209</lpage><pub-id pub-id-type=\"pmid\">9719787</pub-id></element-citation></ref><ref id=\"R33\"><label>33</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Ash</surname><given-names>A</given-names></name><name><surname>Porell</surname><given-names>F</given-names></name><name><surname>Gruenberg</surname><given-names>L</given-names></name><name><surname>Sawitz</surname><given-names>E</given-names></name><name><surname>Beiser</surname><given-names>A</given-names></name></person-group><article-title>Adjusting Medicare capitation payments using prior hospitalization data</article-title><source>Health Care Financ Rev</source><year>1989</year><volume>10</volume><issue>4</issue><fpage>17</fpage><lpage>29</lpage><pub-id pub-id-type=\"pmid\">10313277</pub-id></element-citation></ref><ref id=\"R34\"><label>34</label><element-citation publication-type=\"book\"><person-group person-group-type=\"author\"><name><surname>Palsbo</surname><given-names>SE</given-names></name></person-group><source>The AAPCC Explained</source><year>1991</year><publisher-loc>Washington DC</publisher-loc><publisher-name>Group Health Association of America</publisher-name></element-citation></ref><ref id=\"R35\"><label>35</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Anderson</surname><given-names>GF</given-names></name><name><surname>Steinberg</surname><given-names>EP</given-names></name><name><surname>Powe</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Setting payment rates for capitated systems: a comparison of various alternatives</article-title><source>Inquiry</source><year>1990</year><volume>27</volume><issue>3</issue><fpage>225</fpage><lpage>233</lpage><pub-id pub-id-type=\"pmid\">2145223</pub-id></element-citation></ref><ref id=\"R36\"><label>36</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Blumberg</surname><given-names>LJ</given-names></name><name><surname>Evans</surname><given-names>A</given-names></name></person-group><article-title>Reform of the Medicare AAPCC: learning from previous proposals. Average Adjusted Per Capita Costs</article-title><source>Inquiry</source><year>1998</year><volume>35</volume><issue>1</issue><fpage>62</fpage><lpage>77</lpage><pub-id pub-id-type=\"pmid\">9597018</pub-id></element-citation></ref><ref id=\"R37\"><label>37</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Ellis</surname><given-names>RP</given-names></name><name><surname>Pope</surname><given-names>GC</given-names></name><name><surname>Iezzoni</surname><given-names>L</given-names></name><etal/></person-group><article-title>Diagnosis-based risk adjustment for Medicare capitation payments</article-title><source>Health Care Financ Rev</source><year>1996</year><volume>17</volume><issue>3</issue><fpage>101</fpage><lpage>128</lpage><pub-id pub-id-type=\"pmid\">10172666</pub-id></element-citation></ref><ref id=\"R38\"><label>38</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Selden</surname><given-names>TM</given-names></name></person-group><article-title>A model of capitation</article-title><source>Journal of Health Economics</source><year>1990</year><volume>9</volume><fpage>397</fpage><lpage>409</lpage><pub-id pub-id-type=\"pmid\">10109989</pub-id></element-citation></ref><ref id=\"R39\"><label>39</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Berwick</surname><given-names>DM</given-names></name></person-group><article-title>Quality of health care. Part 5: Payment by capitation and the quality of care [see comments]</article-title><source>N Engl J Med</source><year>1996</year><volume>335</volume><issue>16</issue><fpage>1227</fpage><lpage>1231</lpage><pub-id pub-id-type=\"pmid\">8815948</pub-id></element-citation></ref><ref id=\"R40\"><label>40</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Berwick</surname><given-names>DM</given-names></name></person-group><article-title>Eleven worthy aims for clinical leadership of health system reform</article-title><source>JAMA</source><year>1994</year><volume>272</volume><issue>10</issue><fpage>797</fpage><lpage>802</lpage><pub-id pub-id-type=\"pmid\">8078145</pub-id></element-citation></ref><ref id=\"R41\"><label>41</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Leape</surname><given-names>LL</given-names></name><name><surname>Park</surname><given-names>RE</given-names></name><name><surname>Solomon</surname><given-names>DH</given-names></name><name><surname>Chassin</surname><given-names>MR</given-names></name><name><surname>Kosecoff</surname><given-names>J</given-names></name><name><surname>Brook</surname><given-names>RH</given-names></name></person-group><article-title>Does inappropriate use explain small-area variations in the use of health care services?</article-title><source>JAMA</source><year>1990</year><volume>263</volume><issue>5</issue><fpage>669</fpage><lpage>672</lpage><pub-id pub-id-type=\"pmid\">2404147</pub-id></element-citation></ref><ref id=\"R42\"><label>42</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Gravelle</surname><given-names>HS</given-names></name></person-group><article-title>Economic analysis of health service professions: a survey</article-title><source>Soc Sci Med</source><year>1985</year><volume>20</volume><issue>10</issue><fpage>1049</fpage><lpage>1061</lpage><pub-id pub-id-type=\"pmid\">3892709</pub-id></element-citation></ref><ref id=\"R43\"><label>43</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Angell</surname><given-names>M</given-names></name></person-group><article-title>The doctor as double agent</article-title><source>Kennedy Institute Ethics Journal</source><year>1993</year><volume>3</volume><fpage>279</fpage><lpage>286</lpage></element-citation></ref><ref id=\"R44\"><label>44</label><element-citation publication-type=\"book\"><person-group person-group-type=\"author\"><name><surname>Olson</surname><given-names>M</given-names></name></person-group><source>The logic of collective action; public goods and the theory of groups</source><year>1965</year><publisher-loc>Cambridge, Mass</publisher-loc><publisher-name>Harvard University Press</publisher-name></element-citation></ref><ref id=\"R45\"><label>45</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Pettit</surname><given-names>P</given-names></name></person-group><article-title>The Cunning of Trust</article-title><source>Philosophy and Public Affairs</source><year>1995</year><volume>24</volume><issue>3</issue><fpage>202</fpage><lpage>225</lpage></element-citation></ref><ref id=\"R46\"><label>46</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Alchian</surname><given-names>A</given-names></name><name><surname>Demsetz</surname><given-names>H</given-names></name></person-group><article-title>Production, information costs, and economic organization</article-title><source>American Economic Review</source><year>1972</year><volume>62</volume><fpage>777</fpage><lpage>795</lpage></element-citation></ref><ref id=\"R47\"><label>47</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Gaynor</surname><given-names>M</given-names></name><name><surname>Gertler</surname><given-names>P</given-names></name></person-group><article-title>Moral hazard and risk spreading in partnerships</article-title><source>RAND Journal of Economics</source><year>1995</year><volume>26</volume><fpage>591</fpage><lpage>613</lpage></element-citation></ref><ref id=\"R48\"><label>48</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kuttner</surname><given-names>R</given-names></name></person-group><article-title>Physician-operated networks and the new antitrust guidelines</article-title><source>N Engl J Med</source><year>1997</year><volume>336</volume><issue>5</issue><fpage>386</fpage><lpage>391</lpage><pub-id pub-id-type=\"pmid\">9011808</pub-id></element-citation></ref><ref id=\"R49\"><label>49</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Klein</surname><given-names>SA</given-names></name></person-group><article-title>Antitrust relief moves a step closer to law</article-title><source>AMNews</source><year>2000</year><month>4</month><day>17</day></element-citation></ref><ref id=\"R50\"><label>50</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Roland</surname><given-names>M</given-names></name></person-group><article-title>Linking physicians\\' pay to the quality of care - a major experiment in the United Kingdom</article-title><source>New England Journal of Medicine</source><year>2004</year><volume>351</volume><issue>14</issue><fpage>1448</fpage><lpage>1454</lpage><pub-id pub-id-type=\"pmid\">15459308</pub-id></element-citation></ref><ref id=\"R51\"><label>51</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Rosenthal</surname><given-names>MB</given-names></name><name><surname>Fernandopulle</surname><given-names>R</given-names></name><name><surname>Song</surname><given-names>HR</given-names></name><name><surname>Landon</surname><given-names>B</given-names></name></person-group><article-title>Paying for quality: provider\\'s incentives for quality improvement</article-title><source>Health Affairs (Millwood)</source><year>2004</year><volume>23</volume><fpage>127</fpage><lpage>141</lpage></element-citation></ref><ref id=\"R52\"><label>52</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Epstein</surname><given-names>AM</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name><name><surname>Hammel</surname><given-names>MB</given-names></name></person-group><article-title>Paying physicians for high quality</article-title><source>New England Journal of Medicine</source><year>2004</year><volume>350</volume><fpage>406</fpage><lpage>410</lpage><pub-id pub-id-type=\"pmid\">14736934</pub-id></element-citation></ref><ref id=\"R53\"><label>53</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Chernichovsky</surname><given-names>D</given-names></name><name><surname>Bayulken</surname><given-names>C</given-names></name></person-group><article-title>A pay-for-performance system for civil service doctors: the Indonesian experiment</article-title><source>Soc Sci Med</source><year>1995</year><volume>41</volume><issue>2</issue><fpage>155</fpage><lpage>161</lpage><pub-id pub-id-type=\"pmid\">7667679</pub-id></element-citation></ref><ref id=\"R54\"><label>54</label><element-citation publication-type=\"book\"><person-group person-group-type=\"author\"><name><surname>Axelrod</surname><given-names>RM</given-names></name></person-group><source>The Evolution of Cooperation</source><year>1984</year><publisher-loc>New York</publisher-loc><publisher-name>Basic Books</publisher-name></element-citation></ref><ref id=\"R55\"><label>55</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Orbell</surname><given-names>JM</given-names></name><name><surname>van de Kragt</surname><given-names>AJC</given-names></name><name><surname>Dawes</surname><given-names>RM</given-names></name></person-group><article-title>Explaining discussion-induced cooperation in social dilemmas</article-title><source>Journal of Personality and Social Psychology</source><year>1988</year><volume>54</volume><fpage>811</fpage><lpage>819</lpage></element-citation></ref><ref id=\"R56\"><label>56</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Spann</surname><given-names>S</given-names></name></person-group><article-title>Report on financing the new model of family medicine</article-title><source>Ann Fam Med</source><year>2004</year><volume>2</volume><issue>S3</issue><fpage>S1</fpage><lpage>S21</lpage><pub-id pub-id-type=\"pmid\">15654084</pub-id></element-citation></ref><ref id=\"R57\"><label>57</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Barr</surname><given-names>MS</given-names></name></person-group><article-title>The Need to Test the Patient-Centered Medical Home</article-title><source>JAMA</source><year>2008</year><month>8</month><day>20</day><volume>300</volume><issue>7</issue><fpage>834</fpage><lpage>835</lpage><comment>2008</comment><pub-id pub-id-type=\"pmid\">18714064</pub-id></element-citation></ref><ref id=\"R58\"><label>58</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Robinson</surname><given-names>JC</given-names></name></person-group><article-title>Theory and practice in the design of physician payment incentives</article-title><source>The Milbank Quarterly</source><year>2001</year><volume>79</volume><issue>2</issue><fpage>149</fpage><lpage>177</lpage><pub-id pub-id-type=\"pmid\">11439463</pub-id></element-citation></ref><ref id=\"R59\"><label>59</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Gosden</surname><given-names>T</given-names></name><name><surname>Forland</surname><given-names>F</given-names></name><name><surname>Kristiansen</surname><given-names>IS</given-names></name><etal/></person-group><article-title>Impact of payment method on behaviour of primary care physicians: a systematic review</article-title><source>Journal of Health Services Research and Policy</source><year>2001</year><volume>6</volume><issue>1</issue><fpage>44</fpage><lpage>55</lpage><pub-id pub-id-type=\"pmid\">11219360</pub-id></element-citation></ref><ref id=\"R60\"><label>60</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Berwick</surname><given-names>DM</given-names></name><name><surname>Nolan</surname><given-names>TW</given-names></name><name><surname>Whittington</surname><given-names>J</given-names></name></person-group><article-title>The triple aim: Care, health, and cost</article-title><source>Health Affairs</source><year>2008</year><volume>27</volume><issue>3</issue><fpage>759</fpage><lpage>769</lpage><pub-id pub-id-type=\"pmid\">18474969</pub-id></element-citation></ref><ref id=\"R61\"><label>61</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Lasker</surname><given-names>RD</given-names></name><name><surname>Weiss</surname><given-names>ES</given-names></name><name><surname>Miller</surname><given-names>R</given-names></name></person-group><article-title>Partnership synergy: a practical framework for studying and strengthening the collaborative advantage</article-title><source>The Milbank Quarterly</source><year>2001</year><volume>79</volume><issue>2</issue><fpage>179</fpage><lpage>205</lpage><pub-id pub-id-type=\"pmid\">11439464</pub-id></element-citation></ref><ref id=\"R62\"><label>62</label><element-citation publication-type=\"journal\"><article-title>Goldfarb v. Virginia State Bar (421), (U.S. 773 Supreme Court 1975)</article-title></element-citation></ref><ref id=\"R63\"><label>63</label><element-citation publication-type=\"journal\"><article-title>Arizona v. Maricopa County Medical Society (457), (U.S. 332 Supreme Court 1982)</article-title></element-citation></ref><ref id=\"R64\"><label>64</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Costilo</surname><given-names>LB</given-names></name></person-group><article-title>Antitrust enforcement in health care: ten years after the AMA suit</article-title><source>N Engl J Med</source><year>1985</year><volume>313</volume><fpage>901</fpage><lpage>904</lpage><pub-id pub-id-type=\"pmid\">4033726</pub-id></element-citation></ref><ref id=\"R65\"><label>65</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Havighurst</surname><given-names>C</given-names></name></person-group><article-title>Are the antitrust agencies overregulating physician networks?</article-title><source>Loyola Consumer Law Rep</source><year>1996</year><volume>8</volume><issue>2</issue><fpage>78</fpage></element-citation></ref><ref id=\"R66\"><label>66</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Helmchen</surname><given-names>LA</given-names></name><name><surname>Lo Sasso</surname><given-names>AT</given-names></name></person-group><article-title>How sensitive is physician performance to alternative compensation schedules? Evidence from a large network of primary care clinics</article-title><source>Health Economics</source><year>2010</year><volume>19</volume><fpage>1300</fpage><lpage>1317</lpage><pub-id pub-id-type=\"pmid\">19816948</pub-id></element-citation></ref><ref id=\"R67\"><label>67</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Devlin</surname><given-names>RA</given-names></name><name><surname>Sarma</surname><given-names>S</given-names></name></person-group><article-title>Do physician remuneration schemes matter? The case of Canadian family physicians</article-title><source>Journal of Health Economics</source><year>2008</year><volume>27</volume><fpage>1168</fpage><lpage>1181</lpage><pub-id pub-id-type=\"pmid\">18586341</pub-id></element-citation></ref><ref id=\"R68\"><label>68</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Beasley</surname><given-names>JW</given-names></name><name><surname>Hankey</surname><given-names>TH</given-names></name><name><surname>Erickson</surname><given-names>R</given-names></name><etal/></person-group><article-title>How many problems do family physicians manage at each encounter? A WReN study</article-title><source>Ann Fam Med</source><year>2004</year><volume>2</volume><fpage>405</fpage><lpage>410</lpage><pub-id pub-id-type=\"pmid\">15506571</pub-id></element-citation></ref><ref id=\"R69\"><label>69</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Weingarten</surname><given-names>SR</given-names></name><name><surname>Lloyd</surname><given-names>L</given-names></name><name><surname>Chiou</surname><given-names>CF</given-names></name><name><surname>Braunstein</surname><given-names>GD</given-names></name></person-group><article-title>Do subspecialists working outside of their specialty provide less efficient and lower-quality care to hospitalized patients than do primary care physicians?</article-title><source>Arch Intern Med</source><year>2002</year><volume>162</volume><fpage>527</fpage><lpage>532</lpage><pub-id pub-id-type=\"pmid\">11871920</pub-id></element-citation></ref><ref id=\"R70\"><label>70</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Macinko</surname><given-names>J</given-names></name><name><surname>Starfield</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Politzer</surname><given-names>R</given-names></name></person-group><article-title>Primary care, income inequality, and stroke mortality in the United States: a longitudinal analysis, 1985&#x02013;1995</article-title><source>Stroke</source><year>2003</year><volume>34</volume><fpage>1958</fpage><lpage>1964</lpage><pub-id pub-id-type=\"pmid\">12843344</pub-id></element-citation></ref><ref id=\"R71\"><label>71</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Baicker</surname><given-names>K</given-names></name><name><surname>Chandra</surname><given-names>A</given-names></name></person-group><article-title>Medicare spending, the physician workforce, and beneficiaries\\' quality of care</article-title><source>Health Affairs (Project Hope),. Health Affairs (Project Hope)</source><year>2004</year><volume>Suppl Web Exclusives, W4</volume><fpage>184</fpage><lpage>197</lpage></element-citation></ref><ref id=\"R72\"><label>72</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Greenfield</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>EC</given-names></name><name><surname>Zubkoff</surname><given-names>M</given-names></name><etal/></person-group><article-title>Variations in resource utilization among medical specialties and systems of care. Results from the medical outcomes study</article-title><source>Journal of the American Medical Association</source><year>1992</year><volume>267</volume><fpage>1624</fpage><lpage>1630</lpage><pub-id pub-id-type=\"pmid\">1542172</pub-id></element-citation></ref><ref id=\"R73\"><label>73</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Woodward</surname><given-names>RS</given-names></name><name><surname>Warren-Boulton</surname><given-names>F</given-names></name></person-group><article-title>Considering the effects of financial incentives and professional ethics on \\'appropriate\\' medical care</article-title><source>Journal of Health Economics</source><year>1984</year><volume>3</volume><fpage>223</fpage><lpage>237</lpage><pub-id pub-id-type=\"pmid\">10269802</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id=\"T1\" position=\"float\" orientation=\"portrait\"><label>Table: 1</label><caption><p id=\"P54\">The Prisoner&#x02019;s Dilemma Model.</p></caption><table frame=\"box\" rules=\"all\"><thead><tr><th align=\"left\" rowspan=\"1\" colspan=\"1\"/><th align=\"left\" rowspan=\"1\" colspan=\"1\"><bold>Player 2 (&#x0201c;others&#x0201d;):</bold><break/><bold>COOPERATE</bold></th><th align=\"left\" rowspan=\"1\" colspan=\"1\"><bold>Player 2 (&#x0201c;others&#x0201d;):</bold><break/><bold>DEFECT</bold></th></tr></thead><tbody><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Player 1:</bold><break/><bold>COOPERATE</bold></td><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Player 1 = 3 points<break/>Player 2 = 3 points<break/>= 2<sup>nd</sup> highest payoff for Player 1<break/>= 2<sup>nd</sup> highest payoff for Player 2<break/>(BOX #1)</td><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Player 1 = 0 points<break/>Player 2 = 5 points<break/>= lowest payoff for Player 1<break/>= highest payoff for Player 2<break/>(BOX #2)</td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Player 1:</bold><break/><bold>DEFECT</bold></td><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Player 1 = 5 points<break/>Player 2 = 0 points<break/>= highest payoff for Player 1<break/>= lowest payoff for Player 2<break/>(BOX #3)</td><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Player 1 = 1 point<break/>Player 2=1 point<break/>= 2<sup>nd</sup> lowest payoff for Player 1<break/>= 2<sup>nd</sup> lowest payoff for Player 2<break/>(BOX #4)</td></tr></tbody></table></table-wrap><table-wrap id=\"T2\" position=\"float\" orientation=\"portrait\"><label>Table: 2</label><caption><p id=\"P55\">The Fee-For-Service Model.</p></caption><table frame=\"box\" rules=\"all\"><thead><tr><th align=\"left\" colspan=\"3\" rowspan=\"1\">Provider Payment (PP) = Volume of Services (V) + Quality of Care (Q) + Externalities<break/>(E)<break/>Using these assumptions: V<sub>high</sub>=5, V<sub>low</sub>=3, E<sub>highQ</sub> =&#x02212;1, E<sub>lowQ</sub> =0, Q<sub>high</sub>=&#x02212;2, Q<sub>low</sub>=0.<break/>(no capitation rate, no incentive payment)</th></tr><tr><th align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"/><th align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 2 (P2)</bold><break/><bold>(&#x0201c;others&#x0201d;)</bold><break/><bold>(high volume, low quality)</bold></th><th align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 2 (P2)</bold><break/><bold>(&#x0201c;others&#x0201d;)</bold><break/><bold>(high volume, high quality)</bold></th></tr></thead><tbody><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(high volume,</bold><break/><bold>low quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 5 (5+0+0)<break/>P2 = 5 (5+0+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 4 (5+0&#x02212;1)<break/>P2 = 2 (5&#x02212;2&#x02212;1)</td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(high volume,</bold><break/><bold>high quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 3 (5&#x02212;2+0)<break/>P2 = 5 (5+0+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 2 (5&#x02212;2&#x02212;1)<break/>P2 = 2 (5&#x02212;2&#x02212;1)</td></tr><tr><td align=\"left\" colspan=\"3\" valign=\"top\" rowspan=\"1\"><bold>Results</bold>: the dominant strategy is for all players to provide a high volume of low<break/>quality services.</td></tr></tbody></table></table-wrap><table-wrap id=\"T3\" position=\"float\" orientation=\"portrait\"><label>Table 3</label><caption><p id=\"P56\">The Capitation Model with a Short Time Horizon.</p></caption><table frame=\"box\" rules=\"all\"><thead><tr><th align=\"left\" colspan=\"3\" valign=\"top\" rowspan=\"1\">Provider Payment (PP) = Volume of Services (V) + Quality of Care (Q) + Capitation<break/>Rate (C) + Externalities (E)<break/>Using these assumptions: V<sub>high</sub>= &#x02212;2, V<sub>low</sub> =0; Q<sub>high</sub>=&#x02212;2, Q<sub>low</sub>=0; C= 5; E<sub>highQ</sub>=1, E<sub>lowQ</sub>=0<break/>(no incentive payments)</th></tr><tr><th align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"/><th align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Provider 2 (P2)<break/>(&#x0201c;others&#x0201d;)<break/>(low volume, low quality)</th><th align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Provider 2 (P2)<break/>(&#x0201c;others&#x0201d;)<break/>(low volume, high quality)</th></tr></thead><tbody><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Provider 1<break/>(P1)<break/>(low volume,<break/>low quality)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 5 (0+0+5+0)<break/>P2 = 5 (0+0+5+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 6 (0+0+5+1)<break/>P2 = 4 (0+ &#x02212;2+5+1)</td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1</bold><break/><bold>(P1)</bold><break/><bold>(low volume,</bold><break/><bold>high quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 3 (0+ &#x02212;2+5+0)<break/>P2 = 5 (0+0+5+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 4 (0+ &#x02212;2+5+1)<break/>P2 = 4 (0+ &#x02212;2+5+1)</td></tr><tr><td align=\"left\" colspan=\"3\" rowspan=\"1\"><bold>Results</bold> the dominant strategy is to pursue the highest individual payoff and provide<break/>a low volume of low quality services. There is an individual temptation to free ride<break/>by providing low quality services in a high quality environment [<italic>i.e.,</italic> if others are<break/>providing high quality services, then the exerternalities (E) = 1].</td></tr></tbody></table></table-wrap><table-wrap id=\"T4\" position=\"float\" orientation=\"portrait\"><label>Table: 4</label><caption><p id=\"P57\">The Capitation Model with a Longer Time Horizon.</p></caption><table frame=\"box\" rules=\"all\"><thead><tr><th align=\"left\" colspan=\"3\" rowspan=\"1\">Provider Payment (PP) = Volume of Services (V) + Quality of Care (Q) + Capitation Rate<break/>(C) + Externalities (E)<break/>Using these assumptions: V<sub>high</sub>= &#x02212;2, V<sub>low</sub> =0; Q<sub>high</sub>=&#x02212;2, Q<sub>low</sub>=0; C<sub>highQ</sub>= 5, C<sub>lowQ</sub> = 3; E<sub>highQ</sub>=1, E<sub>lowQ</sub>=0 (no incentive payments)</th></tr><tr><th align=\"left\" rowspan=\"1\" colspan=\"1\"/><th align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Provider 2 (P2)<break/>(&#x0201c;others&#x0201d;)<break/>(low volume, low quality)\\n</th><th align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Provider 2 (P2)<break/>(&#x0201c;others&#x0201d;)<break/>(low volume, high quality)\\n</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(low volume,</bold><break/><bold>low quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 3 (0+0+3+0)<break/>P2 = 3 (0+0+3+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 6 (0+0+5+1)<break/>P2 = 4 (0+ &#x02212;2+5+1)</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(low volume,</bold><break/><bold>high quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 1 (0+ &#x02212;2+3+0)<break/>P2 = 3 (0+0+3+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 4 (0+ &#x02212;2+5+1)<break/>P2 = 4 (0+ &#x02212;2+5+1)</td></tr><tr><td align=\"left\" colspan=\"3\" rowspan=\"1\"><bold>Results</bold> prisoner&#x02019;s dilemma &#x02013; the dominant individual strategy is to provide a low<break/>volume of low quality services. There is the potential for individual and system<break/>improvement with collective action to provide high quality services (which keeps the<break/>capitation rate = 5), but also a temptation for individuals to free ride in this scenario<break/>[<italic>i.e.,</italic> capitation rate stays at 5 if enough others are providing high quality services, and<break/>the externalities (E) = 1].</td></tr></tbody></table></table-wrap><table-wrap id=\"T5\" position=\"float\" orientation=\"portrait\"><label>Table 5</label><caption><p id=\"P58\">Blended Payment Examples.</p></caption><table frame=\"box\" rules=\"all\"><tbody><tr><td align=\"left\" colspan=\"3\" rowspan=\"1\">Provider Payment (PP) = Volume of Services (V) + Quality of Care (Q) + Capitation Rate (C) + Externalities (E) +<break/>Incentive Payments (I)</td></tr><tr><td align=\"left\" colspan=\"3\" rowspan=\"1\"><underline><bold>5a</bold></underline>. Fee-For-Service Dominant Blended Payment with Small Incentive Payment<break/><bold>Using these assumptions: V<sub>high</sub>= 4, V<sub>low</sub>=0; Q<sub>high</sub>=&#x02212;2, Q<sub>low</sub>=0; C= 1; E<sub>highQ</sub>=1, E<sub>lowQ</sub>=0; I<sub>highQ</sub>=1, I<sub>lowQ</sub>=0</bold><break/><bold>Most emphasis on paying for volume of services (V<sub>high</sub>= 4), with small capitation rate (C= 1) and small</bold><break/><bold>incentive payment (I<sub>highQ</sub>=1)</bold></td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"/><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 2 (P2) (&#x0201c;others&#x0201d;)</bold><break/><bold>(high volume, low quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 2 (P2) (&#x0201c;others&#x0201d;)</bold><break/><bold>(high volume, high quality)</bold></td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(high volume,</bold><break/><bold>low quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 5 (4+0+1+0+0)<break/>P2 = 5 (4+0+1+0+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 6 (4+0+1+1+0)<break/>P2 = 5 (4&#x02212;2+1+1+1)</td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(high volume,</bold><break/><bold>high quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 4 (4&#x02212;2+1+0+1)<break/>P2 = 5 (4&#x02212;0+1+0+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 5 (4&#x02212;2+1+1+1)<break/>P2 = 5 (4&#x02212;2+1+1+1)</td></tr><tr><td align=\"left\" colspan=\"3\" rowspan=\"1\"><underline><bold>5b</bold></underline>. Capitation Dominant Blended Payment with Small Incentive Payment<break/><bold>Using these assumptions: V<sub>high</sub>= 1, V<sub>low</sub> =0; Q<sub>high</sub>=&#x02212;2, Q<sub>low</sub>=0; C= 4; E<sub>highQ</sub>=1, E<sub>lowQ</sub>=0; I<sub>highQ</sub>=1, I<sub>lowQ</sub>=0</bold><break/><bold>Most emphasis on capitation rate (C= 4), with small fee for volume of services (V<sub>high</sub>= 1), small incentive</bold><break/><bold>payment (I<sub>highQ</sub>=1)</bold></td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"/><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 2 (P2) (&#x0201c;others&#x0201d;)</bold><break/><bold>(high volume, low quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 2 (P2) (&#x0201c;others&#x0201d;)</bold><break/><bold>(high volume, high quality)</bold></td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(high volume,</bold><break/><bold>low quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 5 (1+0+4+0+0)<break/>P2 = 5 (1+0+4+0+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 6 (1+0+4+1+0)<break/>P2 = 5 (1&#x02212;2+4+1+1)</td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(high volume,</bold><break/><bold>high quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 4 (1&#x02212;2+4+0+1)<break/>P2 = 5 (1+0+4+0+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 5 (1&#x02212;2+4+1+1)<break/>\\nP2 = 5 (1&#x02212;2+4+1+1)</td></tr><tr><td align=\"left\" colspan=\"3\" rowspan=\"1\"><bold>Results for examples a and b</bold>: dominant strategy remains to provide low quality services, but with a reduced risk of<break/>lower payment if a provider chooses to provide high quality services. A small temptation to free ride still exists.</td></tr><tr><td align=\"left\" colspan=\"3\" rowspan=\"1\"><underline><bold>5c</bold></underline>. Fee-For-Service Dominant Blended Payment with Bigger Incentive Payment [and lower &#x0201c;base&#x0201d; payment =<break/>fee-for-service (V<sub>high</sub>= 3) + capitation (1) = 4]<break/><bold>Using these assumptions: V<sub>high</sub>= 3, V<sub>low</sub> =0; Q<sub>high</sub>=&#x02212;2, Q<sub>low</sub>=0; C= 1; E<sub>highQ</sub>=1, E<sub>lowQ</sub>=0; I<sub>highQ</sub>=2, I<sub>lowQ</sub>=0</bold><break/><bold>Less emphasis on paying for volume of services (V<sub>high</sub>= 3), with small capitation rate (C= 1) and larger</bold><break/><bold>incentive payment (I<sub>highQ</sub>=2)</bold></td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"/><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 2 (P2) (&#x0201c;others&#x0201d;)</bold><break/><bold>(high volume, low quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 2 (P2) (&#x0201c;others&#x0201d;)</bold><break/><bold>(high volume, high quality)</bold></td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(high volume,</bold><break/><bold>low quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 4 (3+0+1+0+0)<break/>P2 = 4 (3+0+1+0+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 5 (3+0+1+1+0)<break/>P2 = 5 (3&#x02212;2+1+1+2)</td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(high volume,</bold><break/><bold>high quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 4 (3&#x02212;2+1+0+2)<break/>P2 = 4 (3&#x02212;0+1+0+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 5 (3&#x02212;2+1+1+2)<break/>P2 = 5 (3&#x02212;2+1+1+2)</td></tr><tr><td align=\"left\" colspan=\"3\" rowspan=\"1\"><underline><bold>5d</bold></underline>. Capitation Dominant Blended Payment with Bigger Incentive Payment [and lower &#x0201c;base&#x0201d; payment = fee-for-service (V<sub>high</sub>= 1) + capitation (3) = 4]<break/><bold>Using these assumptions: V<sub>high</sub>= 1, V<sub>low</sub> =0; Q<sub>high</sub>=&#x02212;2, Q<sub>low</sub>=0; C= 3; E<sub>highQ</sub>=1, E<sub>lowQ</sub>=0; I<sub>highQ</sub>=2, I<sub>lowQ</sub>=0</bold><break/><bold>Less emphasis on capitation rate (C= 3), with small fee for volume of services (V<sub>high</sub>= 1), larger incentive</bold><break/><bold>payment (I<sub>highQ</sub>=2)</bold></td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"/><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 2 (P2) (&#x0201c;others&#x0201d;)</bold><break/><bold>(high volume, low quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 2 (P2) (&#x0201c;others&#x0201d;)</bold><break/><bold>(high volume, high quality)</bold></td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(high volume,</bold><break/><bold>low quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 4 (1+0+3+0+0)<break/>P2 = 4 (1+0+3+0+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 5 (1+0+3+1+0)<break/>P2 = 5 (1&#x02212;2+3+1+2)</td></tr><tr><td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><bold>Provider 1 (P1)</bold><break/><bold>(high volume,</bold><break/><bold>high quality)</bold></td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 4 (1&#x02212;2+3+0+2)<break/>P2 = 4 (1+0+3+0+0)</td><td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">P1 = 5 (1&#x02212;2+3+1+2)<break/>P2 = 5 (1&#x02212;2+3+1+2)</td></tr><tr><td align=\"left\" colspan=\"3\" rowspan=\"1\">Results for Examples c and d: no dominant strategy exists. Providers cannot maximize individual gain by providing<break/>low quality services. There is no incentive to free ride. If collective action is encouraged, providers will choose to<break/>maximize individual and collective rewards by delivering a high volume of high quality services.</td></tr></tbody></table></table-wrap></floats-group></article>'\n"
     ]
    }
   ],
   "source": [
    "assert list_tarfiles_to_check(\"OA_Fam\") == [\"comm_use.O-Z.xml.tar.gz\", \"non_comm_use.O-Z.xml.tar.gz\"]\n",
    "\n",
    "get_text_from_tar_file(\"5147743\", list_tarfiles_to_check(\"OA_Fam\"))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "start =  2018-02-02 16:15:18.717345\n",
      "/project/data/comm_use.A-B.xml.tar.gz\n",
      "end =  2018-02-02 16:17:43.825933\n",
      "total =  0:02:25.108762\n",
      "/project/data/non_comm_use.A-B.xml.tar.gz\n",
      "end =  2018-02-02 16:18:34.920062\n",
      "total =  0:03:16.202828\n",
      "/project/data/comm_use.C-H.xml.tar.gz\n",
      "end =  2018-02-02 16:20:57.823095\n",
      "total =  0:05:39.108236\n",
      "/project/data/non_comm_use.C-H.xml.tar.gz\n",
      "end =  2018-02-02 16:22:13.025700\n",
      "total =  0:06:54.308543\n",
      "/project/data/comm_use.I-N.xml.tar.gz\n",
      "end =  2018-02-02 16:24:20.867246\n",
      "total =  0:09:02.150006\n",
      "/project/data/non_comm_use.I-N.xml.tar.gz\n",
      "J_Cell_Biol/PMC2064817.nxml\n",
      "b'<!DOCTYPE article PUBLIC \"-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN\" \"archivearticle.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" article-type=\"research-article\"><?properties open_access?><front><journal-meta><journal-id journal-id-type=\"nlm-ta\">J Cell Biol</journal-id><journal-id journal-id-type=\"publisher-id\">jcb</journal-id><journal-title>The Journal of Cell Biology</journal-title><issn pub-type=\"ppub\">0021-9525</issn><issn pub-type=\"epub\">1540-8140</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=\"pmid\">17470638</article-id><article-id pub-id-type=\"pmc\">2064817</article-id><article-id pub-id-type=\"publisher-id\">200702053</article-id><article-id pub-id-type=\"doi\">10.1083/jcb.200702053</article-id><article-categories><subj-group subj-group-type=\"heading\"><subject>Research Articles</subject><subj-group><subject>Report</subject></subj-group></subj-group></article-categories><title-group><article-title>LKB1 and AMPK maintain epithelial cell polarity under energetic stress</article-title></title-group><contrib-group><contrib contrib-type=\"author\"><name><surname>Mirouse</surname><given-names>Vincent</given-names></name><xref ref-type=\"aff\" rid=\"N0x1acbf50N0x1f5d6e8\">1</xref><xref ref-type=\"aff\" rid=\"N0x1acbf50N0x1f5d6e8\">2</xref></contrib><contrib contrib-type=\"author\"><name><surname>Swick</surname><given-names>Lance L.</given-names></name><xref ref-type=\"aff\" rid=\"aff3\">3</xref></contrib><contrib contrib-type=\"author\"><name><surname>Kazgan</surname><given-names>Nevzat</given-names></name><xref ref-type=\"aff\" rid=\"aff3\">3</xref></contrib><contrib contrib-type=\"author\"><name><surname>St Johnston</surname><given-names>Daniel</given-names></name><xref ref-type=\"aff\" rid=\"N0x1acbf50N0x1f5d6e8\">1</xref><xref ref-type=\"aff\" rid=\"N0x1acbf50N0x1f5d6e8\">2</xref></contrib><contrib contrib-type=\"author\"><name><surname>Brenman</surname><given-names>Jay E.</given-names></name><xref ref-type=\"aff\" rid=\"aff3\">3</xref></contrib></contrib-group><aff id=\"N0x1acbf50N0x1f5d6e8\"><label>1</label>The Gurdon Institute and the <label>2</label>Department of Genetics, University of Cambridge, Cambridge CB2 1QN, England, UK</aff><aff id=\"aff3\"><label>3</label>Cell and Developmental Biology and Neuroscience Center, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, NC 27599</aff><author-notes><fn><p>Correspondence to J. Brenman: <email>brenman@med.unc.edu</email></p></fn></author-notes><pub-date pub-type=\"ppub\"><day>7</day><month>5</month><year>2007</year></pub-date><volume>177</volume><issue>3</issue><fpage>387</fpage><lpage>392</lpage><history><date date-type=\"received\"><day>8</day><month>2</month><year>2007</year></date><date date-type=\"accepted\"><day>26</day><month>3</month><year>2007</year></date></history><copyright-statement>Copyright &#x000a9; 2007, The Rockefeller University Press</copyright-statement><copyright-year>2007</copyright-year><self-uri xlink:title=\"pdf\" xlink:href=\"jcb1770387.pdf\"/><abstract><p>LKB1 is mutated in both familial and spontaneous tumors, and acts as a master kinase that activates the PAR-1 polarity kinase and the adenosine 5&#x02032;monophosphate&#x02013;activated kinase (AMPK). This has led to the hypothesis that LKB1 acts as a tumor suppressor because it is required to maintain cell polarity and growth control through PAR-1 and AMPK, respectively. However, the genetic analysis of LKB1&#x02013;AMPK signaling in vertebrates has been complicated by the existence of multiple redundant AMPK subunits. We describe the identification of mutations in the single <italic>Drosophila melanogaster</italic> AMPK catalytic subunit AMPK&#x003b1;. Surprisingly, <italic>ampk&#x003b1;</italic> mutant epithelial cells lose their polarity and overproliferate under energetic stress. LKB1 is required in vivo for AMPK activation, and <italic>lkb1</italic> mutations cause similar energetic stress&#x02013;dependent phenotypes to <italic>ampk&#x003b1;</italic> mutations. Furthermore, <italic>lkb1</italic> phenotypes are rescued by a phosphomimetic version of AMPK&#x003b1;. Thus, LKB1 signals through AMPK to coordinate epithelial polarity and proliferation with cellular energy status, and this might underlie the tumor suppressor function of LKB1.</p></abstract></article-meta><notes><fn-group><fn><p>V. Mirouse and L.L. Swick contributed equally to this paper.</p></fn><fn><p>Abbreviations used in this paper: AMPK, AMP-activated kinase; aPKC, atypical PKC; MARK, microtubule affinity-regulating kinase.</p></fn></fn-group></notes></front><body><sec><title>Introduction</title><p><italic>LKB1</italic> is a serine/threonine kinase that is mutated in most cases of Peutz-Jeghers syndrome, which is an autosomal dominant disorder in which patients develop benign hamartomas and a high frequency of malignant tumors (<xref ref-type=\"bibr\" rid=\"bib2\">Alessi et al., 2006</xref>). Furthermore, <italic>LKB1</italic> is also mutated in some sporadic cancers, such as 30% of lung adenocarcinomas, and the expression of the kinase is also down-regulated in a substantial proportion of breast cancers (<xref ref-type=\"bibr\" rid=\"bib28\">Sanchez-Cespedes et al., 2002</xref>). In both cases, tumors associated with LKB1 mutations usually derive from epithelial tissue. LKB1 is a master kinase that can potentially activate several downstream kinases by phosphorylating a conserved threonine in their activation loops (<xref ref-type=\"bibr\" rid=\"bib21\">Lizcano et al., 2004</xref>). Two of these kinases have been extensively characterized: PAR-1/microtubule affinity-regulating kinases (MARKs) and AMPK (AMP-activated protein kinase). PAR-1 regulates cell polarity in numerous cell types and organisms (<xref ref-type=\"bibr\" rid=\"bib20\">Kemphues et al., 1988</xref>; <xref ref-type=\"bibr\" rid=\"bib6\">Bohm et al., 1997</xref>; <xref ref-type=\"bibr\" rid=\"bib29\">Shulman et al., 2000</xref>; <xref ref-type=\"bibr\" rid=\"bib4\">Benton and St Johnston, 2003</xref>; <xref ref-type=\"bibr\" rid=\"bib8\">Cohen et al., 2004</xref>). AMPK acts as a cellular energy sensor because it is activated by AMP, which accumulates when ATP levels are low (<xref ref-type=\"bibr\" rid=\"bib19\">Kahn et al., 2005</xref>). AMPK then mediates the cellular response to energetic stress by activating energy-producing activities, while inhibiting energy-consuming ones, such as translation and proliferation. LKB1 regulates both cell polarity and cell growth and division in cell culture and in vivo (<xref ref-type=\"bibr\" rid=\"bib20\">Kemphues et al., 1988</xref>; <xref ref-type=\"bibr\" rid=\"bib32\">Tiainen et al., 1999</xref>; <xref ref-type=\"bibr\" rid=\"bib23\">Martin and St Johnston, 2003</xref>; <xref ref-type=\"bibr\" rid=\"bib3\">Baas et al., 2004</xref>; <xref ref-type=\"bibr\" rid=\"bib26\">Narbonne and Roy, 2006</xref>). One hypothesis envisions LKB1 signaling mediated by PAR-1 regulating cell polarity, whereas LKB1 signaling through AMPK could control cell growth and proliferation. However, recent cell culture experiments suggest that AMPK also plays a role in the polarization of MDCK cells by promoting tight junction assembly (<xref ref-type=\"bibr\" rid=\"bib34\">Zhang et al., 2006</xref>; <xref ref-type=\"bibr\" rid=\"bib35\">Zheng and Cantley, 2007</xref>). We show that LKB1 and AMPK are required to maintain epithelial polarity and integrity under energy-limiting conditions in <italic>Drosophila melanogaster</italic>. Therefore, these results provide a potential mechanism to coordinate the regulation of cell polarity and proliferation with energy conditions within a multicellular animal.</p></sec><sec><title>Results and discussion</title><p>AMPK contains three protein subunits, &#x003b1;, &#x003b2;, and &#x003b3;, which form a heterotrimer. The &#x003b1; subunit (AMPK&#x003b1;) encodes a highly conserved serine/threonine kinase, and the other subunits are regulatory. From a <italic>D. melanogaster</italic> forward genetic screen for mutants affecting larval neuronal dendrite development (<xref ref-type=\"bibr\" rid=\"bib24\">Medina et al., 2006</xref>), we identified several lethal mutations in <italic>AMPK&#x003b1;</italic>. The ethylmethanesulfonate mutants, <italic>ampk&#x003b1;<sup>1</sup></italic> and <italic>ampk&#x003b1;<sup>2</sup></italic>, contain a single amino acid change (S211L, completely conserved) and a premature stop codon (Q295 STOP), respectively, whereas <italic>ampk&#x003b1;<sup>3</sup></italic> has a 16-bp deletion creating a stop codon (Y141 STOP; <xref rid=\"fig1\" ref-type=\"fig\">Fig. 1 A</xref>). All <italic>ampk&#x003b1;</italic> mutants, whether homozygous or in trans with a deletion covering the locus, displayed a completely penetrant and nearly identical phenotype, with greatly enlarged plasma membrane domains in dendrites, but not in axonal compartments (<xref rid=\"fig1\" ref-type=\"fig\">Fig. 1 C</xref>; unpublished data). In addition, <italic>ampk&#x003b1;<sup>1</sup></italic> and <italic>ampk&#x003b1;<sup>3</sup></italic> could be rescued to viability with either a chromosomal duplication carrying a wild-type <italic>ampk&#x003b1;</italic> gene, a wild-type AMPK&#x003b1; transgene, or a transgene that is tagged with the red fluorescent protein mCherry (<xref rid=\"fig1\" ref-type=\"fig\">Fig. 1 D</xref>; see Materials and methods). The requirement for <italic>ampk&#x003b1;</italic> is cell autonomous because transgene expression within only neurons rescues the phenotype (<xref rid=\"fig1\" ref-type=\"fig\">Fig. 1 D</xref>). Therefore, these mutations represent the first knockouts of the single AMPK&#x003b1; catalytic subunit in the <italic>D. melanogaster</italic> genome and allow the genetic analysis of AMPK function in vivo.</p><fig position=\"float\" id=\"fig1\"><label>Figure 1.</label><caption><p><bold>Identification of mutations within the single <italic>D. melanogaster ampk&#x003b1;</italic> gene.</bold> (A) Schematic domain representation of AMPK&#x003b1; and corresponding genetic lesions in mutants. The serine/threonine kinase domain (black, aa 39&#x02013;280) and T-Loop (gray, aa 167&#x02013;194) are shown with the sites of mutations, S211L, Q295STOP, and Y141STOP, for <italic>ampk&#x003b1;<sup>1</sup></italic>, <italic>ampk&#x003b1;<sup>2</sup></italic>, and <italic>ampk&#x003b1;<sup>3</sup></italic>, respectively. (B) Representative image of wild-type da neurons expressing an <italic>Actin&#x02237;GFP</italic> fusion transgene in a second instar larva. (C) <italic>ampk&#x003b1;</italic> mutants display enlarged plasma membrane domains (arrows) in sensory neuron dendrites, but not axons. (D) A wild-type <italic>ampk&#x003b1;</italic> transgene expressed autonomously within da neurons completely rescues the dendrite phenotype. (B&#x02013;D) Background genotypes are <italic>w; Gal4109(2)80, UAS-actin&#x02237;GFP</italic>. Anterior at left and dorsal at top. Bars, 20 &#x003bc;m.</p></caption><graphic xlink:href=\"jcb1770387f01\"></graphic></fig><p>Although <italic>ampk&#x003b1;</italic> mutants display a strong phenotype in larval neuronal dendrites, no phenotype was observed in early larval <italic>lkb1</italic> mutants (unpublished data), probably because of the large maternal contribution of this protein. To explore the relationship between AMPK&#x003b1; and LKB1 function without the confounding issues caused by the differing maternal contributions of each protein, we chose to examine follicle cells of the <italic>D. melanogaster</italic> ovary. The follicle cells that surround the oocyte have a typical epithelial architecture with a highly polarized actin cytoskeleton in which the apical surface is marked by dense actin bundles in the apical microvilli, the lateral cortex is covered by a thin actin mesh, and the basal side contains a prominent network of parallel actin stress fibers. This polarized organization of actin typifies many epithelia, including the main mammalian tissue culture model for polarized epithelial cells, MDCK cells (<xref ref-type=\"bibr\" rid=\"bib12\">Fievet et al., 2004</xref>). We did not observe any actin phenotypes in <italic>ampk&#x003b1;<sup>3</sup></italic> mutant follicle cells using standard detection procedures (<xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 A</xref>). Because AMPK is maximally activated under low cellular energy levels, we also tested the influence of energy stress by strongly reducing the availability of sugar in the <italic>D. melanogaster</italic> culture medium. Under these conditions, <italic>ampk&#x003b1;<sup>3</sup></italic> mutant cells display a strong actin phenotype (<xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 A</xref>). The density of basal stress fibers is strongly reduced, whereas the amount of apical F-actin increases. This phenotype is highly penetrant under these starvation conditions (98%; <italic>n</italic> &#x0003d; 49) and is also observed with the two other alleles of <italic>ampk&#x003b1;</italic>.</p><fig position=\"float\" id=\"fig2\"><label>Figure 2.</label><caption><p><bold><italic>ampk&#x003b1;</italic> is required to maintain epithelial polarity under energetic stress.</bold> (A) <italic>ampk&#x003b1;<sup>3</sup></italic> mutant follicle cell clones under normal (left) or energetic stress conditions (right). Mutant cells are marked by the absence of GFP (green). Markers are indicated to the left, as follows: F-actin, red; Dlg, red; aPKC, blue; Crb, red; Cora, blue; <italic>D</italic>ECad, red; and Dg, blue. The apical domain is at the top and faces the oocyte, which also contains a layer of cortical actin (top). (B) <italic>ampk&#x003b1;<sup>3</sup></italic> clone stained for DNA (blue) and Baz (red). Baz is usually present at the apical domain of mutant cells, but is lost in the most severely affected clones that lose their epithelial organization and form multiple layers. (C) <italic>ampk&#x003b1;<sup>3</sup></italic> clone stained for DNA (blue) and Dlg (red). Large <italic>ampk&#x003b1;<sup>3</sup></italic> clones at the anterior or posterior poles of the egg chamber overproliferate to form tumorlike structures composed of unpolarized cells. (D) <italic>tend</italic> mutant cells stained for aPKC (blue) and Dlg (red). Cells maintain normal epithelial polarity. (E) <italic>ampk&#x003b1;<sup>3</sup></italic> clone from a female fed on a glucose-only diet stained for aPKC (blue) and Dlg (red). These conditions of protein and lipid starvation do not affect the polarity of <italic>ampk&#x003b1;<sup>3</sup></italic> mutant cells. The stage (st) of the egg chamber is indicated on each picture.</p></caption><graphic xlink:href=\"jcb1770387f02\"></graphic></fig><p>Because this phenotype reflects a disruption of the apical&#x02013;basal polarity of the actin cytoskeleton, we examined other polarity markers within these cells. <italic>ampk&#x003b1;</italic> mutant clones induced in adult flies fed with high-sugar diets did not show any polarity phenotypes, which is consistent with the absence of an actin phenotype under these conditions (<xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 A</xref>). Under energetic starvation conditions, however, <italic>ampk&#x003b1;</italic> mutant cells show a fully penetrant loss of polarity. Apical markers, such as atypical PKC (aPKC) and Crumbs (Crb) lose their cortical localization completely and appear to be down-regulated, as do the lateral markers Discs large (Dlg) and Coracle (Cora; <xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 A</xref>). In contrast, Dystroglycan (Dg), which is normally enriched at the basal cortex, extends into the lateral domain, and occasionally even reaches the apical membrane (<xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 A</xref>). This suggests that the phenotype represents an expansion of the basal domain at the expense of the lateral and apical domains.</p><p>Although most aspects of apical&#x02013;basal polarity are completely disrupted in <italic>ampk&#x003b1;</italic> mutant clones under energetic stress, E-cadherin (ECad) is usually still enriched at the adherens junctions, suggesting that the altered polarity is not a secondary consequence of a loss of intercellular adhesion. The subapical localization of Bazooka (Baz) with cadherin is also maintained in most cases (<xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 B</xref>). This indicates that Baz is not in a complex with aPKC in columnar follicle cells, but is instead associated with the adherens junctions, as has recently been described in the <italic>D. melanogaster</italic> embryo and in neuroepithelial cells of the Zebrafish neural tube (<xref ref-type=\"bibr\" rid=\"bib16\">Harris and Peifer, 2005</xref>; <xref ref-type=\"bibr\" rid=\"bib1\">Afonso and Henrique, 2006</xref>).</p><p>A considerable proportion of <italic>ampk&#x003b1;</italic> mutant clones show a more severe phenotype, in which the cells round up and lose their epithelial organization to form multiple layers of cells (<xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 B</xref>). In these cases, Baz is now also absent from the cell cortex. Finally, larger mutant clones, particularly at the anterior or the posterior of the egg chamber, show a complete loss of epithelial organization and overproliferate to form small, tumorlike growths (<xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 C</xref>).</p><p>As one proposed function for AMPK is to sense and maintain cellular ATP levels, the polarity phenotype observed under starvation conditions could be caused by low cellular ATP concentrations. To test this hypothesis, we examined cells that were mutant for <italic>tenured</italic> (<italic>tend</italic>). Tend encodes a mitochondrial cytochrome oxidase subunit; therefore, mutants have reduced intracellular ATP concentrations to levels sufficient to maintain cell survival and growth, but not cell division (<xref ref-type=\"bibr\" rid=\"bib22\">Mandal et al., 2005</xref>). This cell cycle block is believed to require AMPK activation. In agreement with a role for Tend in cell cycle progression, we did not observe <italic>tend</italic> clones bigger than four to six cells under energetic starvation conditions (<xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 D</xref>). In contrast to <italic>ampk&#x003b1;</italic> mutant cells, however, <italic>tend</italic> mutant cells showed no polarity defects, ruling out the possibility that the <italic>ampk&#x003b1;</italic> phenotype is a secondary effect of low ATP levels. We also tested the effect of specific nutrient starvation by feeding flies only glucose, but these conditions did not induce any polarity phenotypes in <italic>ampk&#x003b1;</italic> mutant cells (<xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 E</xref>). Thus, AMPK&#x003b1; is specifically required to maintain epithelial polarity and growth control under conditions of energetic stress.</p><p>Because our results indicate that <italic>ampk&#x003b1;</italic> plays a role in epithelial polarity, we assessed whether the localization of the protein itself is polarized. We also examined LKB1 localization, as it is a potential regulator of AMPK. Transgenic wild-type fusion proteins for both AMPK&#x003b1; and LKB1 rescue lethal null mutants to viability, and should therefore mimic the localizations of the endogenous proteins. LKB1-GFP is mainly found at the apical and lateral cortex of the follicle cells, and is absent from the basal domain (<xref rid=\"fig3\" ref-type=\"fig\">Fig. 3 A</xref>). This basal exclusion is surprising, as cortical localization of LKB1 requires its membrane targeting by prenylation of a conserved CAAX motif (<xref ref-type=\"bibr\" rid=\"bib23\">Martin and St Johnston, 2003</xref>). This suggests that the lipid composition of the basal domain is different from the rest of the plasma membrane and/or that LKB1 posttranslational modifications are asymmetrically controlled. In contrast, mCherry-AMPK&#x003b1; does not show any enrichment or asymmetric localization at the plasma membrane, and it is found distributed throughout the cytoplasm, but absent from the nucleus (<xref rid=\"fig3\" ref-type=\"fig\">Fig. 3 A</xref>). The localization of LKB1 suggests that AMPK could be activated specifically at the apical and lateral cortices of the cells. To test this hypothesis, we used an antibody against the LKB1 phosphorylation site of AMPK (phospho-T184). The immunostaining is reduced to background levels in both <italic>ampk&#x003b1;</italic> and <italic>lkb1</italic> mutant clones. This confirms the specificity of the antibody and indicates that LKB1 is the principle AMPK kinase in these cells (<xref rid=\"fig3\" ref-type=\"fig\">Fig. 3 B</xref>). In wild-type cells, PhosphoT184-AMPK is found diffusely in the cytoplasm (<xref rid=\"fig3\" ref-type=\"fig\">Fig. 3 B</xref>). The effect of AMPK on apical&#x02013;basal polarity is therefore not related to a polarized distribution of the kinase or its localized activation by LKB1.</p><fig position=\"float\" id=\"fig3\"><label>Figure 3.</label><caption><p><bold>AMPK&#x003b1; activation is not polarized.</bold> (A) Follicle cells expressing Cherry-AMPK&#x003b1; (left) and GFP-LKB1 (right). (B) Wild-type follicle cells (green) adjacent to <italic>ampk&#x003b1;<sup>3</sup></italic> (left) or <italic>lkb1<sup>4A4-2</sup></italic> (right) mutant cells marked by the loss of GFP stained for PhosphoT184-AMPK&#x003b1; (red, top; white, bottom).</p></caption><graphic xlink:href=\"jcb1770387f03\"></graphic></fig><p>Because LKB1 activates AMPK, we wondered if similar phenotypes could be observed in <italic>lkb1</italic> mutant cells. <italic>lkb1</italic> clones can lead to severe polarity defects in follicle cells in normally fed flies (<xref ref-type=\"bibr\" rid=\"bib23\">Martin and St Johnston, 2003</xref>). However, these defects are observed only in large clones that are induced in the stem cells that give rise to the follicular epithelium, whereas small <italic>lkb1</italic> mutant clones, which are induced after the formation of the epithelium, have no effect on follicle cell polarity or the organization of the actin cytoskeleton (<italic>n</italic> &#x0003d; 24; <xref rid=\"fig4\" ref-type=\"fig\">Fig. 4 A</xref>). This suggests that LKB1 is required for the establishment of epithelial polarity in well-fed flies, but not for its maintenance, as is the case for PAR-1 (<xref ref-type=\"bibr\" rid=\"bib10\">Doerflinger et al., 2003</xref>). In contrast, under conditions of glucose starvation, small <italic>lkb1</italic> clones that were induced after the formation of the follicular epithelium show a fully penetrant polarity phenotype (100%; <italic>n</italic> &#x0003d; 21). Under these conditions, we observed a loss of the polarized localization of Dlg, aPKC, Crb, and Cora (<xref rid=\"fig4\" ref-type=\"fig\">Fig. 4 A</xref>). However, Baz distribution is usually not affected by <italic>lkb1</italic> loss of function (unpublished data). Dg extends laterally and occasionally localizes to the apical domain (<xref rid=\"fig4\" ref-type=\"fig\">Fig. 4 A</xref>). The actin cytoskeleton is also disturbed, with more F-actin apically and a decreased density of stress fibers on the basal side. Finally, large <italic>lkb1</italic> clones lose their epithelial organization completely and overproliferate to form small neoplasms (<xref rid=\"fig4\" ref-type=\"fig\">Fig. 4, B and C</xref>). Thus, <italic>lkb1</italic> mutant cells exhibit identical phenotypes to <italic>ampk&#x003b1;</italic> mutant cells under low-energy conditions.</p><fig position=\"float\" id=\"fig4\"><label>Figure 4.</label><caption><p><bold>LKB1 is required to maintain epithelial polarity under energetic starvation conditions.</bold> (A) <italic>lkb1<sup>4A</sup></italic> mutant follicle cell clones under normal (left) or energetic stress conditions (right). Mutant cells are marked by the absence of GFP (green) and visualized with the same markers (at left) as described in <xref rid=\"fig2\" ref-type=\"fig\">Fig. 2 A</xref>. (B) <italic>lkb<sup>4</sup></italic> clone stained for DNA (blue) and Dlg (red, left) or <italic>D</italic>ECad (red, right). Large mutant clones at the anterior or posterior poles of the egg chamber overproliferate to form tumorlike aggregates of unpolarized cells.</p></caption><graphic xlink:href=\"jcb1770387f04\"></graphic></fig><p>Because <italic>lkb1</italic> and <italic>ampk&#x003b1;</italic> mutant clones lead to very similar polarity defects and LKB1 phosphorylates AMPK&#x003b1;, we wondered if a constitutively active form of AMPK&#x003b1; could rescue the <italic>lkb1</italic> phenotype. Therefore, we generated transgenic lines carrying a <italic>UAS-AMPK&#x003b1;</italic> construct, in which Threonine184 is replaced by an aspartate, which should mimic the activating phosphorylation of this site by LKB1 (<xref ref-type=\"bibr\" rid=\"bib21\">Lizcano et al., 2004</xref>). The expression of the <italic>AMPK&#x003b1;-T184D</italic> transgene in <italic>lkb1</italic> mutant clones fully rescues their starvation-dependent polarity and overproliferation phenotypes (<italic>n</italic> &#x0003d; 37), whereas the Gal4 driver alone has no effect (<xref rid=\"fig5\" ref-type=\"fig\">Fig. 5</xref>). Furthermore, AMPK&#x003b1;-T184D&#x02013;expressing mutant clones also have a normal actin cytoskeleton (100%; <italic>n</italic> &#x0003d; 13; <xref rid=\"fig5\" ref-type=\"fig\">Fig. 5</xref>). Thus, the phosphomimetic version of AMPK&#x003b1; completely rescues the <italic>lkb1</italic> mutant phenotype under conditions of energetic stress.</p><fig position=\"float\" id=\"fig5\"><label>Figure 5.</label><caption><p><bold>The AMPK&#x003b1;-T184D phosphomimetic transgene rescues the starvation-dependent <italic>lkb1</italic> phenotypes.</bold> <italic>lkb1</italic> mutant cells marked by the absence of GFP (green) expressing the <italic>UAS</italic>-AMPK&#x003b1;-T184D transgene. The expression of the phosphomimetic <italic>AMPK&#x003b1;</italic> transgene (T184D) rescues the <italic>lkb1</italic> energetic stress&#x02013;dependent phenotypes, as indicated by the normal distribution of various polarity markers (indicated to the left or right of the images). (top) F-actin and DECad, red; DG, blue. (bottom) Dlg and Crb, red; aPKC and Cora, blue.</p></caption><graphic xlink:href=\"jcb1770387f05\"></graphic></fig><p>The recovery of null mutations in <italic>ampk&#x003b1;</italic> has allowed the first in vivo analysis of AMPK function in a multicellular organism, which has revealed an unexpected role for the kinase in the maintenance of epithelial polarity, but only under conditions of energetic stress. This implies that at least one of the pathways that normally maintain cell polarity cannot function when cellular energy levels are too low, and that AMPK activation compensates for this defect.</p><p>A surprising feature of the <italic>ampk&#x003b1;</italic> polarity phenotype is that it has opposite effects on the actin cytoskeleton and the cortical polarity cues. In mildly affected clones, basal actin is strongly reduced, with a corresponding increase in the amount of apical actin. In contrast, mutant clones show an expansion of the basal markers into the lateral and apical regions, as well as a loss of lateral and apical markers. Thus, the effects on actin may be independent of other polarity defects, suggesting that AMPK acts though different pathways to regulate actin and cortical polarity in opposite ways.</p><p>It is unclear how AMPK regulates the actin cytoskeleton, but it is possible that it acts on only one side of the cell and that the reciprocal changes on the other are caused by a change in the concentration of free G-actin or an actin nucleator, as has been shown for <italic>abl</italic> mutants during cellularization (<xref ref-type=\"bibr\" rid=\"bib14\">Grevengoed et al., 2003</xref>). For example, loss of AMPK could increase actin polymerization apically, thereby depleting the pool of free actin that can polymerize basally. Alternatively, <italic>ampk&#x003b1;</italic> mutants may prevent the formation of basal actin stress fibers, and thus increase the concentration of free actin, which enhances apical actin polymerization.</p><p>The cortical polarity defects of <italic>ampk&#x003b1;</italic> mutant clones also suggest a reciprocal relationship between the basal and apical/lateral membrane domains because the basal domain, marked by Dg, is dramatically expanded, whereas the determinants for the lateral domain (Dlg) and the apical domain (aPKC and Crb) disappear from the cortex. This suggests that there is some form of mutual antagonism between the basal and lateral domains that maintains a sharp boundary between them, as has been described for apical and lateral domains through the inhibitory phosphorylation of Baz (PAR-3) by lateral PAR-1, and of PAR-1 by apical aPKC (<xref ref-type=\"bibr\" rid=\"bib4\">Benton and St Johnston, 2003</xref>; <xref ref-type=\"bibr\" rid=\"bib30\">Suzuki et al., 2004</xref>). If this model is correct, AMPK could be required to restrict the extent of the basal domain, with the expansion of this domain in <italic>ampk&#x003b1;</italic> mutants leading to the exclusion of lateral and apical markers. Indeed, the overexpression of Dg has been found to cause a similar loss of apical and lateral markers to that seen in <italic>ampk&#x003b1;</italic> clones (<xref ref-type=\"bibr\" rid=\"bib9\">Deng et al., 2003</xref>). Alternatively, AMPK could be necessary to maintain the localization of the apical and lateral determinants, which in turn prevent the basal domain from extending into these regions.</p><p>Mutations in <italic>AMPK</italic> not only disrupt the polarity of the follicle cell epithelium, but also cause the cells to overproliferate, giving rise to a tumorous phenotype. One possible explanation for this phenotype is that it is caused by the mislocalization and down-regulation of Dlg. Dlg is a member of a class of tumor suppressors in <italic>D. melanogaster</italic> that also includes Lgl and Scribble, and follicle cell clones mutant for any of these genes overproliferate to form invasive tumors that are similar to those formed by <italic>ampk&#x003b1;</italic> and <italic>lkb1</italic> clones under low-energy conditions (<xref ref-type=\"bibr\" rid=\"bib5\">Bilder and Perrimon, 2000</xref>; <xref ref-type=\"bibr\" rid=\"bib13\">Goode et al., 2005</xref>; <xref ref-type=\"bibr\" rid=\"bib15\">Hariharan and Bilder, 2006</xref>). Furthermore, the tumor suppressor function of these proteins is probably conserved in humans because Scribble restricts proliferation by repressing the G1/S transition, and is a target of the papilloma virus E6 oncoprotein (<xref ref-type=\"bibr\" rid=\"bib25\">Nagasaka et al., 2006</xref>; <xref ref-type=\"bibr\" rid=\"bib31\">Takizawa et al., 2006</xref>). This may account for the observation that AMPK is required to trigger the G1/S checkpoint under conditions of energetic stress (<xref ref-type=\"bibr\" rid=\"bib22\">Mandal et al., 2005</xref>). However, it has also been shown in mammals that AMPK activates TSC2 to repress the insulin&#x02013;TOR pathway, and thus it functions as a tumor suppressor that inhibits cell growth and division (<xref ref-type=\"bibr\" rid=\"bib17\">Inoki et al., 2003</xref>, <xref ref-type=\"bibr\" rid=\"bib18\">2005</xref>). Loss of this repression might provide an alternative explanation for the overgrowth of <italic>ampk&#x003b1;</italic> mutant clones.</p><p>Although the molecular pathways involved remain to be elucidated, our results demonstrate that <italic>ampk&#x003b1;</italic> mutant cells lose their polarity under low-energy conditions and overproliferate to give rise to tumorlike growths. The activation of AMPK depends on its phosphorylation by LKB1, and loss of LKB1 produces an identical tumorous phenotype. Thus, the novel functions of AMPK reported in this work may provide a basis for the tumor suppressor function of LKB1.</p></sec><sec sec-type=\"materials|methods\"><title>Materials and methods</title><sec><title>Mutant characterization</title><p>An ethylmethanesulfonate mutagenesis screen on the X chromosome was performed as previously described (<xref ref-type=\"bibr\" rid=\"bib24\">Medina et al., 2006</xref>). Early second instar larvae were visually screened for dendritic defects using fluorescent microscopy. The <italic>ampk&#x003b1;</italic> mutants, lethal at late second instar stages, were mapped to &#x0223c;150 kb on the X chromosome using a molecularly defined deficiency (<italic>Df[1]Exel6227</italic>), an undefined deficiency (<italic>Df[1]AD11</italic>), and a duplication of the Y chromosome (<italic>Dp[1;Y]/Df[1]svr</italic>). Predicted coding regions for genes in the region were sequenced using PCR amplicons made from mutant genomic DNA, and one gene (<italic>AMPK&#x003b1;</italic>; <italic>CG3051</italic>; NM_057965) was discovered that had mutations in all three alleles.</p></sec><sec><title>Construction of <italic>AMPK&#x003b1;</italic> transgenes</title><p>The wild-type <italic>AMPK&#x003b1;</italic> transgene was cloned into the <italic>pUAST</italic> vector (<xref ref-type=\"bibr\" rid=\"bib7\">Brand and Perrimon, 1993</xref>) as an EcoRI&#x02013;BglII fragment of an EST, corresponding to an <italic>AMPK&#x003b1;-RA</italic> transcript (<ext-link ext-link-type=\"uri\" xlink:href=\"www.flybase.org\">www.flybase.org</ext-link>). The mCherry-AMPK&#x003b1; fusion protein was made using a mCherry construct (provided by R. Tsien, University of California, San Diego, San Diego, CA) at the N terminus fused in-frame to <italic>AMPK&#x003b1;</italic> into the <italic>pUAST</italic> vector. The <italic>UAS-mCherry-AMPK&#x003b1;</italic> transgene rescues viability and fertility when expressed by <italic>Ubiquitin-Gal4</italic> in either <italic>ampk&#x003b1;<sup>1</sup></italic> or <italic>ampk&#x003b1;<sup>3</sup></italic> mutants. The phosphomimetic activated form of AMPK&#x003b1; (AMPK&#x003b1; T184D) was made by PCR-based, site-directed mutagenesis converting base C549 to G549. The transgenes were introduced into a <italic>w<sup>1118</sup></italic> stock by <italic>P</italic> element&#x02013;mediated transformation.</p></sec><sec><title>Fly stocks and crosses</title><p><italic>AMPK&#x003b1;</italic> alleles were recombined with <italic>FRT101</italic> for mitotic recombination. Other mutant stocks used were <italic>FRT82B, lkb<sup>4A4-2</sup></italic> and <italic>FRT82B, tend. UAS:Cherry-AMPK&#x003b1;</italic> and <italic>UAS:GFP-LKB1</italic> were expressed in follicle cells using the <italic>Cy2-Gal4</italic> driver. Flip-out experiments were performed by crossing <italic>UAS:Cherry-AMPK&#x003b1;</italic> and <italic>UAS:AMPK&#x003b1;-T184D</italic> to <italic>y, w, hs:Flp; tub-FRT-cc-FRT-Gal4, UAS:GFP</italic> and heat-shocking pupae. For rescue experiments, two independent stocks were established and crossed together: <italic>w</italic>; <italic>UAS:AMPK&#x003b1;-T184D/CyO; FRT82B, Ubi:nlsGFP</italic> and <italic>y</italic>, <italic>w</italic>, <italic>hs:flp; da:Gal4, FRT82B,lkb1<sup>4A4-2</sup>/TM3,Sb.</italic></p></sec><sec><title>Starvation conditions and clone induction</title><p>Adult flies were placed in vials containing &#x0201c;normal&#x0201d; <italic>D. melanogaster</italic> food media (5% glucose, 5% yeast extract, 3.5% wheat flour, and agar 0.8%), energetic starvation medium (1% yeast extract, 3.5% wheat flour, and agar 0.8%), or specific nutrient-starvation medium (5% glucose and agar 0.8%). Clones were induced by heat-shocking adult females at 37&#x000b0;C for 2 h on two consecutive days. Females were dissected 2 d after the last heat shock.</p></sec><sec><title>Staining and imaging procedures</title><p>Immunofluorescence on ovaries was performed using standard procedures. Primary antibodies were used as follows: rat anti-<italic>D</italic>ECad (1:1,000; <xref ref-type=\"bibr\" rid=\"bib27\">Oda et al., 1994</xref>); mouse anti-Crb (cq4; 1:50; Developmental Studies Hybridoma Bank); Guinea pig anti-Cora (1:2,000; <xref ref-type=\"bibr\" rid=\"bib11\">Fehon et al., 1994</xref>)<italic>;</italic> rabbit anti-aPKC (1:500; Sigma-Aldrich); rat anti-Baz (1:500; <xref ref-type=\"bibr\" rid=\"bib33\">Wodarz et al., 1999</xref>), mouse anti-Dlg (1:50; Developmental Studies Hybridoma Bank); rabbit anti-Dg (1:1,000; <xref ref-type=\"bibr\" rid=\"bib9\">Deng et al., 2003</xref>); and rabbit anti&#x02013;phospoT385-AMPK (1:100; Cell Signaling Technology). Actin staining was performed with rhodamine-conjugated phalloidin (Invitrogen). Second instar larvae were dissected in 4% paraformaldehyde, as previously described (<xref ref-type=\"bibr\" rid=\"bib24\">Medina et al., 2006</xref>). Secondary antibodies coupled with Cy5 (anti&#x02013;rabbit and anti&#x02013;guinea pig) or Texas red (anti&#x02013;mouse and anti&#x02013;rabbit; Jackson Immuno-Research Laboratories; 1:500) were used. Images of follicle cells were collected on a confocal microscope (Radiance 2000; Bio-Rad Laboratories) with a 40&#x000d7;/1.3 NA objective (Plan Fluor; Nikon) using LaserSharp software. Live images of dendrite morphology were acquired using a confocal microscope (LSM 510; Carl Zeiss MicroImaging, Inc.) by using the 488-nm argon line to excite GFP. Larvae were covered in a glycerol solution at 22&#x000b0;C and gently covered with a coverslip (22 &#x000d7; 50 mm; Fisher Scientific) to restrict movement, but not cause bursting of the body wall. Images were taken using a Pan-Neofluar 40&#x000d7;/1.3 NA oil immersion lens with a 2-&#x003bc;m optical slice and LSM Imaging software (Carl Zeiss MicroImaging, Inc.). Images were resized and cropped with Photoshop (Adobe), and imported into Illustrator (Adobe) for labels and arrangement.</p></sec></sec></body><back><ack><p>We are grateful to those who generously sent stocks and reagents. We thank Pierre Leopold for helpful advice on starvation conditions.</p><p>V. Mirouse was supported by the European Molecular Biology Organization, and D. St Johnston was supported by the Wellcome Trust. Grants from the National Institute of Mental Health (MH073155) and the Whitehall Foundation to J.E. Brenman and the National Science Foundation to L. Swick also supported this work.</p></ack><ref-list><ref id=\"bib1\"><citation citation-type=\"journal\">Afonso, C., and D. Henrique. <year>2006</year>. PAR3 acts as a molecular organizer to define the apical domain of chick neuroepithelial cells. <source>J. Cell Sci.</source> <volume>119</volume>:<fpage>4293</fpage>&#x02013;4304.<pub-id pub-id-type=\"pmid\">17003110</pub-id></citation></ref><ref id=\"bib2\"><citation citation-type=\"journal\">Alessi, D.R., K. Sakamoto, and J.R. Bayascas. <year>2006</year>. Lkb1-dependent signaling pathways. <source>Annu. Rev. Biochem.</source> <volume>75</volume>:<fpage>137</fpage>&#x02013;163.<pub-id pub-id-type=\"pmid\">16756488</pub-id></citation></ref><ref id=\"bib3\"><citation citation-type=\"journal\">Baas, A.F., J. Kuipers, N.N. van der Wel, E. Batlle, H.K. Koerten, P.J. Peters, and H.C. Clevers. <year>2004</year>. Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. <source>Cell.</source> <volume>116</volume>:<fpage>457</fpage>&#x02013;466.<pub-id pub-id-type=\"pmid\">15016379</pub-id></citation></ref><ref id=\"bib4\"><citation citation-type=\"journal\">Benton, R., and D. St Johnston. <year>2003</year>. <italic>Drosophila</italic> PAR-1 and 14-3-3 inhibit Bazooka/PAR-3 to establish complementary cortical domains in polarized cells. <source>Cell.</source> <volume>115</volume>:<fpage>691</fpage>&#x02013;704.<pub-id pub-id-type=\"pmid\">14675534</pub-id></citation></ref><ref id=\"bib5\"><citation citation-type=\"journal\">Bilder, D., and N. Perrimon. <year>2000</year>. Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. <source>Nature.</source> <volume>403</volume>:<fpage>676</fpage>&#x02013;680.<pub-id pub-id-type=\"pmid\">10688207</pub-id></citation></ref><ref id=\"bib6\"><citation citation-type=\"journal\">Bohm, H., V. Brinkmann, M. Drab, A. Henske, and T.V. Kurzchalia. <year>1997</year>. Mammalian homologues of <italic>C. elegans</italic> PAR-1 are asymmetrically localized in epithelial cells and may influence their polarity. <source>Curr. Biol.</source> <volume>7</volume>:<fpage>603</fpage>&#x02013;606.<pub-id pub-id-type=\"pmid\">9259552</pub-id></citation></ref><ref id=\"bib7\"><citation citation-type=\"journal\">Brand, A.H., and N. Perrimon. <year>1993</year>. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. <source>Development.</source> <volume>118</volume>:<fpage>401</fpage>&#x02013;415.<pub-id pub-id-type=\"pmid\">8223268</pub-id></citation></ref><ref id=\"bib8\"><citation citation-type=\"journal\">Cohen, D., P.J. Brennwald, E. Rodriguez-Boulan, and A. M&#x000fc;sch. <year>2004</year>. Mammalian PAR-1 determines epithelial lumen polarity by organizing the microtubule cytoskeleton. <source>J. Cell Biol.</source> <volume>164</volume>:<fpage>717</fpage>&#x02013;727.<pub-id pub-id-type=\"pmid\">14981097</pub-id></citation></ref><ref id=\"bib9\"><citation citation-type=\"journal\">Deng, W.M., M. Schneider, R. Frock, C. Castillejo-Lopez, E.A. Gaman, S. Baumgartner, and H. Ruohola-Baker. <year>2003</year>. Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila. <source>Development.</source> <volume>130</volume>:<fpage>173</fpage>&#x02013;184.<pub-id pub-id-type=\"pmid\">12441301</pub-id></citation></ref><ref id=\"bib10\"><citation citation-type=\"journal\">Doerflinger, H., R. Benton, J.M. Shulman, and D. St Johnston. <year>2003</year>. The role of PAR-1 in regulating the polarised microtubule cytoskeleton in the <italic>Drosophila</italic> follicular epithelium. <source>Development.</source> <volume>130</volume>:<fpage>3965</fpage>&#x02013;3975.<pub-id pub-id-type=\"pmid\">12874119</pub-id></citation></ref><ref id=\"bib11\"><citation citation-type=\"journal\">Fehon, R.G., I.A. Dawson, and S. Artavanis-Tsakonas. <year>1994</year>. A <italic>Drosophila</italic> homologue of membrane-skeleton protein 4.1 is associated with septate junctions and is encoded by the coracle gene. <source>Development.</source> <volume>120</volume>:<fpage>545</fpage>&#x02013;557.<pub-id pub-id-type=\"pmid\">8162854</pub-id></citation></ref><ref id=\"bib12\"><citation citation-type=\"journal\">Fievet, B.T., A. Gautreau, C. Roy, L. Del Maestro, P. Mangeat, D. Louvard, and M. Arpin. <year>2004</year>. Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin. <source>J. Cell Biol.</source> <volume>164</volume>:<fpage>653</fpage>&#x02013;659.<pub-id pub-id-type=\"pmid\">14993232</pub-id></citation></ref><ref id=\"bib13\"><citation citation-type=\"journal\">Goode, S., J. Wei, and S. Kishore. <year>2005</year>. Novel spatiotemporal patterns of epithelial tumor invasion in <italic>Drosophila</italic> discs large egg chambers. <source>Dev. Dyn.</source> <volume>232</volume>:<fpage>855</fpage>&#x02013;864.<pub-id pub-id-type=\"pmid\">15712204</pub-id></citation></ref><ref id=\"bib14\"><citation citation-type=\"journal\">Grevengoed, E.E., D.T. Fox, J. Gates, and M. Peifer. <year>2003</year>. Balancing different types of actin polymerization at distinct sites: roles for Abelson kinase and Enabled. <source>J. Cell Biol.</source> <volume>163</volume>:<fpage>1267</fpage>&#x02013;1279.<pub-id pub-id-type=\"pmid\">14676307</pub-id></citation></ref><ref id=\"bib15\"><citation citation-type=\"journal\">Hariharan, I.K., and D. Bilder. <year>2006</year>. Regulation of imaginal disc growth by tumor-suppressor genes in <italic>Drosophila.</italic> <source>Annu. Rev. Genet.</source> <volume>40</volume>:<fpage>335</fpage>&#x02013;361.<pub-id pub-id-type=\"pmid\">16872256</pub-id></citation></ref><ref id=\"bib16\"><citation citation-type=\"journal\">Harris, T.J., and M. Peifer. <year>2005</year>. The positioning and segregation of apical cues during epithelial polarity establishment in <italic>Drosophila.</italic> <source>J. Cell Biol.</source> <volume>170</volume>:<fpage>813</fpage>&#x02013;823.<pub-id pub-id-type=\"pmid\">16129788</pub-id></citation></ref><ref id=\"bib17\"><citation citation-type=\"journal\">Inoki, K., T. Zhu, and K.L. Guan. <year>2003</year>. TSC2 mediates cellular energy response to control cell growth and survival. <source>Cell.</source> <volume>115</volume>:<fpage>577</fpage>&#x02013;590.<pub-id pub-id-type=\"pmid\">14651849</pub-id></citation></ref><ref id=\"bib18\"><citation citation-type=\"journal\">Inoki, K., M.N. Corradetti, and K.L. Guan. <year>2005</year>. Dysregulation of the TSC-mTOR pathway in human disease. <source>Nat. Genet.</source> <volume>37</volume>:<fpage>19</fpage>&#x02013;24.<pub-id pub-id-type=\"pmid\">15624019</pub-id></citation></ref><ref id=\"bib19\"><citation citation-type=\"journal\">Kahn, B.B., T. Alquier, D. Carling, and D.G. Hardie. <year>2005</year>. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. <source>Cell Metab.</source> <volume>1</volume>:<fpage>15</fpage>&#x02013;25.<pub-id pub-id-type=\"pmid\">16054041</pub-id></citation></ref><ref id=\"bib20\"><citation citation-type=\"journal\">Kemphues, K.J., J.R. Priess, D.G. Morton, and N.S. Cheng. <year>1988</year>. Identification of genes required for cytoplasmic localization in early <italic>C. elegans</italic> embryos. <source>Cell.</source> <volume>52</volume>:<fpage>311</fpage>&#x02013;320.<pub-id pub-id-type=\"pmid\">3345562</pub-id></citation></ref><ref id=\"bib21\"><citation citation-type=\"journal\">Lizcano, J.M., O. Goransson, R. Toth, M. Deak, N.A. Morrice, J. Boudeau, S.A. Hawley, L. Udd, T.P. Makela, D.G. Hardie, and D.R. Alessi. <year>2004</year>. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. <source>EMBO J.</source> <volume>23</volume>:<fpage>833</fpage>&#x02013;843.<pub-id pub-id-type=\"pmid\">14976552</pub-id></citation></ref><ref id=\"bib22\"><citation citation-type=\"journal\">Mandal, S., P. Guptan, E. Owusu-Ansah, and U. Banerjee. <year>2005</year>. Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in <italic>Drosophila.</italic> <source>Dev. Cell.</source> <volume>9</volume>:<fpage>843</fpage>&#x02013;854.<pub-id pub-id-type=\"pmid\">16326395</pub-id></citation></ref><ref id=\"bib23\"><citation citation-type=\"journal\">Martin, S.G., and D. St Johnston. <year>2003</year>. A role for <italic>Drosophila</italic> LKB1 in anterior-posterior axis formation and epithelial polarity. <source>Nature.</source> <volume>421</volume>:<fpage>379</fpage>&#x02013;384.<pub-id pub-id-type=\"pmid\">12540903</pub-id></citation></ref><ref id=\"bib24\"><citation citation-type=\"journal\">Medina, P.M., L.L. Swick, R. Andersen, Z. Blalock, and J.E. Brenman. <year>2006</year>. A novel forward genetic screen for identifying mutations affecting larval neuronal dendrite development in <italic>Drosophila melanogaster.</italic> <source>Genetics.</source> <volume>172</volume>:<fpage>2325</fpage>&#x02013;2335.<pub-id pub-id-type=\"pmid\">16415365</pub-id></citation></ref><ref id=\"bib25\"><citation citation-type=\"journal\">Nagasaka, K., S. Nakagawa, T. Yano, S. Takizawa, Y. Matsumoto, T. Tsuruga, K. Nakagawa, T. Minaguchi, K. Oda, O. Hiraike-Wada, et al. <year>2006</year>. Human homolog of <italic>Drosophila</italic> tumor suppressor Scribble negatively regulates cell-cycle progression from G1 to S phase by localizing at the basolateral membrane in epithelial cells. <source>Cancer Sci.</source> <volume>97</volume>:<fpage>1217</fpage>&#x02013;1225.<pub-id pub-id-type=\"pmid\">16965391</pub-id></citation></ref><ref id=\"bib26\"><citation citation-type=\"journal\">Narbonne, P., and R. Roy. <year>2006</year>. Inhibition of germline proliferation during <italic>C. elegans</italic> dauer development requires PTEN, LKB1 and AMPK signalling. <source>Development.</source> <volume>133</volume>:<fpage>611</fpage>&#x02013;619.<pub-id pub-id-type=\"pmid\">16407400</pub-id></citation></ref><ref id=\"bib27\"><citation citation-type=\"journal\">Oda, H., T. Uemura, Y. Harada, Y. Iwai, and M. Takeichi. <year>1994</year>. A <italic>Drosophila</italic> homolog of cadherin associated with armadillo and essential for embryonic cell-cell adhesion. <source>Dev. Biol.</source> <volume>165</volume>:<fpage>716</fpage>&#x02013;726.<pub-id pub-id-type=\"pmid\">7958432</pub-id></citation></ref><ref id=\"bib28\"><citation citation-type=\"journal\">Sanchez-Cespedes, M., P. Parrella, M. Esteller, S. Nomoto, B. Trink, J.M. Engles, W.H. Westra, J.G. Herman, and D. Sidransky. <year>2002</year>. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. <source>Cancer Res.</source> <volume>62</volume>:<fpage>3659</fpage>&#x02013;3662.<pub-id pub-id-type=\"pmid\">12097271</pub-id></citation></ref><ref id=\"bib29\"><citation citation-type=\"journal\">Shulman, J.M., R. Benton, and D. St Johnston. <year>2000</year>. The <italic>Drosophila</italic> homolog of <italic>C. elegans</italic> PAR-1 organizes the oocyte cytoskeleton and directs oskar mRNA localization to the posterior pole. <source>Cell.</source> <volume>101</volume>:<fpage>377</fpage>&#x02013;388.<pub-id pub-id-type=\"pmid\">10830165</pub-id></citation></ref><ref id=\"bib30\"><citation citation-type=\"journal\">Suzuki, A., M. Hirata, K. Kamimura, R. Maniwa, T. Yamanaka, K. Mizuno, M. Kishikawa, H. Hirose, Y. Amano, N. Izumi, et al. <year>2004</year>. aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity. <source>Curr. Biol.</source> <volume>14</volume>:<fpage>1425</fpage>&#x02013;1435.<pub-id pub-id-type=\"pmid\">15324659</pub-id></citation></ref><ref id=\"bib31\"><citation citation-type=\"journal\">Takizawa, S., K. Nagasaka, S. Nakagawa, T. Yano, K. Nakagawa, T. Yasugi, T. Takeuchi, T. Kanda, J.M. Huibregtse, T. Akiyama, and Y. Taketani. <year>2006</year>. Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli. <source>Genes Cells.</source> <volume>11</volume>:<fpage>453</fpage>&#x02013;464.<pub-id pub-id-type=\"pmid\">16611247</pub-id></citation></ref><ref id=\"bib32\"><citation citation-type=\"journal\">Tiainen, M., A. Ylikorkala, and T.P. Makela. <year>1999</year>. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. <source>Proc. Natl. Acad. Sci. USA.</source> <volume>96</volume>:<fpage>9248</fpage>&#x02013;9251.<pub-id pub-id-type=\"pmid\">10430928</pub-id></citation></ref><ref id=\"bib33\"><citation citation-type=\"journal\">Wodarz, A., A. Ramrath, U. Kuchinke, and E. Knust. <year>1999</year>. Bazooka provides an apical cue for Inscuteable localization in <italic>Drosophila</italic> neuroblasts. <source>Nature.</source> <volume>402</volume>:<fpage>544</fpage>&#x02013;547.<pub-id pub-id-type=\"pmid\">10591216</pub-id></citation></ref><ref id=\"bib34\"><citation citation-type=\"journal\">Zhang, L., J. Li, L.H. Young, and M.J. Caplan. <year>2006</year>. AMP-activated protein kinase regulates the assembly of epithelial tight junctions. <source>Proc. Natl. Acad. Sci. USA.</source> <volume>103</volume>:<fpage>17272</fpage>&#x02013;17277.<pub-id pub-id-type=\"pmid\">17088526</pub-id></citation></ref><ref id=\"bib35\"><citation citation-type=\"journal\">Zheng, B., and L.C. Cantley. <year>2007</year>. Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase. <source>Proc. Natl. Acad. Sci. USA.</source> <volume>104</volume>:<fpage>819</fpage>&#x02013;822.<pub-id pub-id-type=\"pmid\">17204563</pub-id></citation></ref></ref-list></back></article>\\n\\n\\n'\n"
     ]
    }
   ],
   "source": [
    "list_tar = [\"comm_use.A-B.xml.tar.gz\", \"non_comm_use.A-B.xml.tar.gz\", \"comm_use.C-H.xml.tar.gz\", \"non_comm_use.C-H.xml.tar.gz\", \"comm_use.I-N.xml.tar.gz\", \"non_comm_use.I-N.xml.tar.gz\", \"comm_use.O-Z.xml.tar.gz\", \"non_comm_use.O-Z.xml.tar.gz\"]\n",
    "\n",
    "get_text_from_tar_file(\"2064817\", list_tar)\n",
    "\n",
    "\n",
    "# PMID: 17470638 PMCID: PMC2064817 DOI: 10.1083/jcb.200702053\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:Python3]",
   "language": "python",
   "name": "conda-env-Python3-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
